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1.1.  Current state of care in deafness 
Nowadays, if a child is born with, or acquires (e.g. as a result of meningitis) severe or 
profound bilateral hearing loss, in Western Europe standard care consists of bilateral 
cochlear implantation. Children without additional problems (like cognitive deficits) who 
receive a cochlear implant at an early age achieve speech perception scores in quiet from 
80-95%1,2. Approximately 60% of these children can attend mainstream education3,4. 
Attending mainstream education enables them to acquire language and educational 
levels that are comparable to those of their normal hearing peers5. Due to its success, the 
audiologic criteria for cochlear implantation have shifted over the years from profound to 
severe bilateral sensorineural hearing loss. In adults, cochlear implantation has become a 
treatment option for significant age-related hearing loss refractory to hearing aids, and it 
is even considered for the suppression of unilateral tinnitus6 and restoring hearing in 
unilateral sensorineural hearing loss7.
1.2.  The inner ear
In a normal hearing ear, sound waves are transferred by the tympanic membrane and 
middle ear ossicles to the peri- and endolymfatic fluid and basilar membrane in the 
cochlea (Fig. 1). Waves run from the oval window through the scala vestibuli and media to 
the apex of the cochlea and then back through the scala tympani to the round window. 
Because of the decreasing stiﬀness of the basilar membrane (which separates the scala 
media from the scala tympani) towards the apex of the cochlea, high frequency sounds 
cause peak amplitudes of the basilar membrane at the base of the cochlea and low 
frequency sounds cause peak amplitudes more apically. This mechanical property of the 
basilar membrane forms the basis for cochlear tonotopy. The outer hair cells in the organ 
of Corti amplify this peak amplitude, resulting in the depolarization of local inner hair cells 
that release a neurotransmitter which triggers an action potential in the cochlear nerve 
fibers. This nerve impulse then travels through the brainstem to the auditory cortex where 
it is perceived as sound 8. Sensorineural hearing loss is in most cases caused by disorders 
of the hair cells of the organ of Corti. This inhibits the conversion of pressure waves in the 
cochlear fluids into nerve impulses.
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1.4.  Early experiments
Benjamin Wilson is often credited with the first attempt to restore hearing in a deaf person 
using electricity. In 1748 he used a Leyden jar to administer electric shocks to a 28-year-old 
woman who was “so deaf as not to hear any one, unless they were very near, and spoke loud to 
her”. After 3 sessions, her hearing improved significantly. Although Wilson suggested that 
“the cause of this deafness might proceed from some obstruction in the auditory nerves, which 
might probably be removed by the violent eﬀects of this subtile electric matter”, the fact that 
her deafness “proceeded […] from a cold” and her hearing improved the most after she 
blew her nose (“when there issued corrupted matter”), it might be considered that she 
actually suﬀered from otitis media with eﬀusion. Especially since experiments on 6 other 
persons with deafness were unsuccessful10. 
 Alessandro Volta was the first to report the perception of sound induced by electricity 
in a normal hearing person when he placed two metal rods in his ears that were connected 
to a battery: “j’ai reçu une secousse dans la tête; et, quelques moments après, (…) j’ai commencé 
à sentir un son, ou plutôt un bruit, dans les oreilles, que je ne saurois bien définir; c’étoit une 
espèce de craquement à secousse, ou petillement, comme si quelque pâte ou matière tenace 
bouillonot”. The experience made him not want to repeat the experiment11.  Stevens et al., 
who conducted similar experiments with alternating current on this ‘electrophonic 
phenomenon’, reported the identification of diﬀerent frequencies and even popular 
1.3.  Contemporary cochlear implants
The external part of a cochlear implant consists of a sound processor (mostly worn behind 
the ear) that captures sound with one or more microphones and breaks down its temporal 
and spectral features through a number of band-pass filters (Fig. 2). The output of each filter 
corresponds to a diﬀerent electrode of the implanted array. These signals are conveyed 
down a cable to the headpiece, which contains a radio frequency transmitting coil and is 
fixed on the skin by a magnet that is located in the internal device. The transmitting coil 
sends the coded signals transcutaneously to the antenna of the internal device, which is 
placed in a bed drilled in the temporal bone. Its electronics package then decodes the 
radio frequency signals and sends them to the array of electrodes that is inserted in the scala 
tympani through a fenestration anteroinferior to the round window or through the round 
window itself.  The current from the electrodes directly depolarizes the auditory neurons, 
bypassing the malfunctioning organ of Corti and the mechanism of neurotransmitter 
release9.
Figure 1  A Schematic representation of the ear. 1: tympanic membrane; 2: middle ear 
ossicles; 3: oval window; 4: round window; 5: cochlea; 6: cochlear nerve.  B Section through 
turn of the cochlear. 7: scala vestibuli; 8: inner hair cell; 9: scala media; 10: outer hair cells; 
11: cochlear nerve fibers; 12: scala tympani; 13: basilar membrane. Figure 2  A contemporary cochlear implant.
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This was a study on 13 subjects with a functioning (single-channel) cochlear implant that 
concluded: ‘‘although the subjects could not understand speech through their prostheses, they 
did score significantly higher on tests of lipreading and recognition of environmental sounds 
with their prostheses activated than without them”20.
 Various multichannel devices that are similar to modern-day cochlear implants were 
then developed by Ingeborg and Erwin Hochmair in Austria and by Graeme Clark in 
Australia21,22. Tyler et al. traveled to implant centers around the world to test various devices 
in a uniform way and reported superior speech perception with these multichannel 
implants23,24. A further improvement was achieved when Blake Wilson et al. introduced a 
new sound processing strategy (Continuous Interleaved Sampling) in 1991, oﬀering speech 
recognition without lipreading to the majority of the patients25.
1.6.  Limitations
Although cochlear implants have risen far above the initial expectation that they would 
only be an aid for lipreading, they also have their limitations: they do not restore normal 
hearing, outcomes vary among patients, performance is considerably degraded by 
ambient noise, and music perception is limited26. Several mechanisms are responsible for 
these limitations: 
I. The distance between the stimulating electrodes and the target neurons impede 
eﬃcient stimulation. The site of activation is assumed to be the cell bodies of spiral 
ganglion neurons or, in some cases, surviving peripheral nerve fibers within the 
osseous spiral lamina. The electrodes of a cochlear implant are separated from these 
target neurons or cell bodies by the bony modiolar wall and are bathed in perilymph, 
an excellent conducting solution. This leads to spread of current in the cochlea, 
decreased specificity of stimulation and increased electrical current requirements27. 
The resulting overlap of excited neural populations probably limits the number of 
eﬀective channels to no more than 4-8 (although contemporary implants have 12-22 
intracochlear electrodes)28, while simulations in normal hearing subjects suggest that 
speech perception continues to improve up to 10-20 channels, depending on the 
diﬃculty of the test29,30.
II. Trauma to the intracochlear structures during insertion of the electrode array (such as 
fracture of the osseous spiral lamina and disruption of the basilar membrane) may 
lead to loss of residual hearing or reduced postoperative speech perception scores31,32.
III. It is diﬃcult to access the tonotopic locations representing the lower frequencies, 
which are located at the apex of the cochlea. This results in a “high-pitch” sound 
quality upon initial stimulation with standard electrode arrays33.
tunes12, and were also able to stimulate the auditory nerve in patients without an ear drum 
and middle ear ossicles by placing an electrode on the oval or round window. They were 
however, not able to produce auditory sensations in patients who were completely deaf 
(at least not without stimulating the facial or vestibular nerve), but suggested that 
“there may be exceptions to this rule”13. The Swedish neurosurgeon Lundberg was the first 
to directly stimulate the auditory nerve of a patient during brain surgery in 1950 and 
“discovered that the sinusoidal current is perceived not as a tone but as a noise”14. 
1.5.  Development of the cochlear implant
The first electronic auditory implant, was in fact an intraneural implant. In 1957, a by 
André Djourno developed device was implanted by Charles Eyriès in a patient with bilateral 
deafness and bilateral facial paralysis after cholesteatoma surgery. During a procedure 
that was intended for facial nerve grafting, Eyriès inserted an isolated wire electrode in a 
segment of the cochlear nerve that was exposed through a breach in the labyrinth. Three 
days later, stimulation with bursts of a 100-Hz impulse signal administered 15 to 20 times 
per minute led to a sound perception the patient compared with the “chant de la cigale ou 
du grillon, ou à des coups de siﬄet à roulette”. And although “la parole […] était absolument 
inintelligible”, the patient was able to easily recognize simple words in a closed set after a 
few practice sessions15.
 Inspired by this research, William House implanted the first true (intrascalar) cochlear 
implant in two deaf patients in 1961. A single gold wire electrode was placed in the scala 
tympani (thus not in direct contact with the cochlear nerve) and the patients reported 
hearing the electrical stimuli. The first patient was reimplanted with a 5-wire electrode 
array which allowed some basic frequency discrimination and the identification of words 
in a small closed set16,17.
 Another intraneural implantation was performed by Simmons in 1964, who implanted 
a deaf-blind volunteer with a cluster of 6 wire electrodes in the modiolus (the conical 
shaped central axis of the cochlea where the spiral ganglion of the cochlear nerve is 
located). The patient reported variations in pitch when diﬀerent electrodes were 
stimulated (due to the tonotopy of the cochlear nerve) and also with variations in stimulus 
frequency (up to 300 pulse/sec)18. Nevertheless, cochlear implants were eventually favored 
over intraneural implants. 
 In France, a multichannel cochlear implant was developed in which 7 electrodes 
were introduced in the cochlea trough separate fenestrations of the scala tympani. 
Implantation of 7 patients in 1976 revealed that “though the intelligibility of word lists remained 
poor, nearly 50 percent of a usual conversation could be understood without lip reading”19.
 The research on intrascalar cochlear implants was boosted when the “Bilger report” 
(commissioned by The United States National Institutes of Health) was published in 1977. 
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1.8.  Aims and outline of this thesis
Cochlear implantation is a successful treatment for severe to profound bilateral sensori -
neural hearing loss. This thesis aims to increase this success by addressing three directions 
for improvement. 
 The first goal is to find the best low-dose imaging technique for postoperative 
evaluation of cochlear implantation. This kind of imaging is necessary for the evaluation of 
new implant designs and research on the relationship between intracochlear electrode 
positioning and hearing outcome. In part II the possibilities of postoperative imaging 
using low-dose multi-slice-, and cone-beam computed tomography for evaluating 
insertion depth, insertion trauma, and precise electrode position are described.  
 The second goal is to quantify medical complications and device failures in cochlear 
implantation and to find ways to reduce them, which is the subject of part III. In chapter 3, 
a method for the uniform registration and classification of complications is proposed. 
A database system that enables fast and accurate data entry was developed and made 
freely available. This cochlear implant complication database was applied in chapter 4, 
which describes the complications and failures of over 1,300 cochlear implantations. 
These results were analyzed to identify risk factors and to propose means to reduce the 
number of complications. A novel way to manage postoperative infections using implantable 
gentamicin-impregnated collagen sponges, is reported in chapter 5.
 The third goal is to develop a surgical approach for cochlear nerve implantation, 
because it may overcome limitations inherent to cochlear implantation. In part IV, the 
feasibility of penetrating cochlear nerve implantation in humans is explored in a temporal 
bone and imaging study: in chapter 6 by means of a transcochlear approach that allows 
access to the modiolus and in chapter 7 by means of a infralabyrinthine approach that 
allows access to the cochlear nerve and may preserve cochlear integrity.
IV. The envelope extraction algorithms common to cochlear implant signal processing 
probably lead to a loss of temporal fine structure information28.
V. Cochlear implantation in totally ossified/malformed cochleae often results in poor 
speech perception stimulation34,35. Furthermore, patients with otosclerosis frequently 
experience facial nerve stimulation36.
VI. The rate of medical complications reported in cochlear implantation is considerable, 
even up to 63%. Although most of these complications are minor (such as transient 
taste disorder or vertigo), these also include major complications such as wound 
infections requiring revision surgery or explantation in 1.6-3.5%37-39.
1.7.  Improving results
There are several ways to overcome the aforementioned limitations. First, by improving 
implant designs, it may be possible to bring electrode contacts closer to the target 
neurons (e.g. with modiolar hugging electrode arrays), to reduce trauma to the intra- 
cochlear structures (e.g. with thinner mid scala electrode arrays) or to achieve deeper 
insertions (e.g. with long straight electrode arrays). In order to evaluate the clinical eﬀects 
of such new implant designs, it is important to determine the exact location of the 
implanted electrodes and the amount of insertion trauma, and correlate this with speech 
perception scores. Because the latter can only be investigated in clinical trials, this requires 
reliable (preferably low-dose) high resolution imaging techniques. 
 There is a need to reduce the number of medical complications in cochlear implantation. 
Most often, minor complications may be countered and treated eﬀectively. Major 
complications however have a great impact on CI recipients and frequently lead to loss of 
the implant. In order to evaluate the magnitude of this important issue, it is necessary to 
identify the most common and most severe complications. If risk factors can be found for 
these complications, adjustments in the surgical procedure or perioperative care may lead 
to a lower complication rate.
 A completely diﬀerent approach is to investigate other sites of electrical stimulation. 
Because placing electrodes in direct contact with the target neurons reduces stimulation 
thresholds and spread of excitation, it is worth to reconsider intraneural implantation 
(see 1.5). Preliminary studies in cats have indeed shown that thresholds for neural excitation 
are as much as 50-fold lower than with conventional scala tympani stimulation, the 
interference between electrodes stimulated simultaneously is markedly reduced, and the 
entire cochlear frequency range (including the lower frequencies) can be accessed40. 
Moreover, this would solve problems with implantation in ossified/malformed cochleae.
II |  Postoperative imaging of  
cochlear implantation
2.  Cone-beam versus multi-slice  
computed tomography 
Published as:
Cone-beam CT versus multi-slice CT systems for postoperative imaging of  
cochlear implantation--a phantom study on image quality and radiation exposure  
using human temporal bones.
Theunisse HJ, Joemai RM, Maal TJ, Geleijns J, Mylanus EA, Verbist BM.
Otol Neurotol. 2015 Apr;36(4):592-9. 
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2.1.  Introduction
Three imaging techniques are commonly used for postoperative evaluation of cochlear 
implants: plain X-ray radiography, single-slice or multi-slice (fan-beam) CT and, more 
recently, flat-panel volume or cone-beam CT (CBCT). 
 Plain X-ray radiography is a cheap, fast, widely available and low-radiation dose 
technique, but it does not provide the 3D information needed to assess the configuration of 
the electrode array. 
 Multi-slice computed tomography (MSCT) provides information on insertion depth, 
insertion trauma and precise electrode position41-46 and allows for visual comparison of 
diﬀerent surgical approaches45,47. There are, however, diﬀerences among MSCT scanners 
and not all systems allow identification of individual electrodes of a 22-electrode array48.
 CBCT has been described in multiple studies as a low-dose alternative to MSCT that 
has superior image quality49-57. CBCT systems operate a cone-shaped X-ray beam and 
provide high-resolution 3D imaging of high contrast structures such as cochlear implants 
but provide poor soft tissue contrast. In 2002, Husstedt et al. demonstrated the feasibility 
of imaging intracochlear electrode positions in a temporal bone with a CBCT system 
incorporated in a biplane digital subtraction angiography system49. CBCT was then used 
to successfully determine the scalar localization of the electrode array in adult patients58,59. 
In 2009, Ruivo et al. also reported that CBCT devices are capable of depicting in vivo 
cochlear implant arrays with very few artifacts and allow precise assessment of intra -
cochlear electrode position with a fraction of the radiation dose required in MSCT51. Direct 
comparisons of image quality between CBCT and MSCT in the evaluation of cochlear 
implants in temporal bone specimens were reported, but there were substantial diﬀerences 
in radiation exposure41,50,52. To our knowledge, no dose-matched comparisons of image 
quality have been published.
 This study compares image quality of two CBCT and two MSCT systems. The primary 
objective of this study was to evaluate the radiation dose and image quality of CBCT 
against clinical and low dose MSCT for postoperative cochlear imaging. The secondary 
objective was to evaluate the eﬀect of dose reduction in MSCT on image quality.
2.2.  Materials and methods
Temporal bones 
Five formalin-fixed human temporal bones were implanted with a Nucleus 24 Contour 
Advance Practice Electrode (Cochlear Ltd, Lane Cove, Australia). This electrode array has a 
small, non-uniform spacing of the 22 half-banded platinum electrodes (0.8 mm at the 
basal end to 0.4 mm apically), which makes the highest demands on spatial resolution. 
After cortical mastoidectomy and posterior tympanotomy, a cochleostomy opening was 
Abstract
Image quality of low-dose multi-slice computed tomography (MSCT) after cochlear 
implantation is comparable to that of cone-beam computed tomography (CBCT). CBCT 
has been described as a low-dose alternative with superior image quality to MSCT for 
postoperative cochlear implant (CI) imaging, but to our knowledge, no dose-matched 
comparisons of image quality have been published. Five human cochleae were implanted 
with CI electrodes and scanned on 2 CBCT and 2 MSCT systems. Four independent 
observers rated aspects of image quality on a 5-point scale. CBCT scans were compared 
to clinical and dose-matched MSCT scans. Declining-dose MSCT protocols were compared 
to the clinical protocol. CT phantoms were used to determine eﬀective dose and resolution 
for each acquisition protocol. Eﬀective dose of the CBCT protocols was 6 to 16% of the 
clinical MSCT dose. Visibility of cochlear inner and outer walls and overall image quality 
were positively correlated with radiation dose on MSCT and image quality was better with 
clinical MSCT than with CBCT protocols. In other comparisons diﬀerences between systems 
were found, but a distinction between CBCT and MSCT could not be made. CBCT and 
dose-matched MSCT are both suitable for postoperative CI imaging. Selecting a CT 
system and radiation dose depends on which cochlear structures need to be visualized.
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Spatial resolution
Measurements of point-spread function (PSF) were performed with a 0.18 mm tungsten 
bead in a plastic cylindrical phantom of 150 mm diameter. Resolution was quantified by 
measuring the full-width at half maximum (FWHM) of the PSF curve. Binary images were 
calculated from the axial images with a threshold at 1000 Hounsfield units (HU). With the 
binary images, the center of the bead was determined by the recording of pixel values in 
three dimensions (x, y, and z) as function of distance to the center of the bead over a 
distance of 5 mm followed by a baseline correction on the resulting curves. FWHM was 
measured in x and y directions (in-plane) and in z direction (longitudinal).
Subjective image quality assessment
The acquired images were transferred to a dedicated workstation (Vitrea 2; Vital Images, 
Minnetonka, Minn, USA). Multi-planar reconstructions (MPRs) were created perpendicular 
to the mid-modiolar axis (plane D, Fig. 1). Four quadrants were defined using a crosshair 
with its origin on the mid-modiolar axis and the x-axis through the center of the round 
window. This method is in accordance with the international consensus on cochlear 
coordinate systems63. In addition to the defined MPR plane, two perpendicular planes 
along the x-axis and y-axis were collected (planes A and B, Fig. 1). These settings were 
drilled anterior and inferior to the round window membrane. The array was inserted using 
the Advance Oﬀ Stylet technique and full insertion was accomplished in all temporal 
bones. The array was fixed to both the cochleostomy opening and the facial recess 
using Loctite 495 cyanoacrylate (Henkel, Düsseldorf, Germany) to prevent displacement. 
The otic capsule and part of the extracochlear electrode array were removed from the 
temporal bone and used to create human head phantoms. Each phantom consisted of 
a plastic cylindrical ring with a density similar to bone 60 (0.5 cm thick, 4 cm high and 
17.5 cm in diameter) in which the otic capsule (in a latex balloon filled with formalin) was 
embedded in gelatin in an eccentric position.
Data acquisition
Images were collected using two MSCT systems (Aquilion 64, Toshiba Medical Systems, 
Otawara, Japan; and Somaton Sensation 64, Siemens Healthcare, Erlangen, Germany) and 
two CBCT systems (iCAT 3D Imaging System, Imaging Sciences International Inc, Hatfield, 
USA; and ILUMA Ultra Cone Beam CT scanner, 3M IMTEC Imaging, Ardmore, USA). The 
phantoms were positioned perpendicular to the axis of the CT scanners to simulate 
clinical conditions.
To investigate the eﬀect of radiation dose on image quality, MSCT acquisitions were 
performed at five tube currents (Table 1). The tube current values on MSCT systems were 
selected to achieve similar radiation dose on both MSCT systems. Other acquisition and 
reconstruction parameters were adapted from the routine clinical CI protocols. The 
Sensation 64 did not allow scanning at the lowest eﬀective dose value of 0.03 mSv and, 
therefore, the lowest dose scan for this system was performed at a tube current of 15 mA. 
This corresponds with an eﬀective dose of 0.07 mSv. CBCT acquisitions were performed 
according to manufacturers’ protocols (i.e. one single-acquisition on each CBCT system). 
Dosimetry
CT output was evaluated by measuring the normalized computed tomographic dose 
index assessed with a 100-mm standard pencil dose chamber (CTDI100, mGy/mAs) using 
the clinical CI acquisition protocol in a standard 16 cm cylindrical CT dose head phantom. 
A calibrated 102-mm-long CT ionization chamber (model CP-4C; Capintec, Ramsey, NJ) was 
used connected to a dosimeter (model 35050A; Keithley Instruments, Cleveland, Ohio). 
Eﬀective dose for MSCT and CBCT acquisitions were estimated by calculating the 
dose-length product (i.e. multiplying the weighted CTDI [CTDIw] with a scan length of 6 
cm). To calculate eﬀective dose, this dose-length product was multiplied by a conversion 
factor of 0.0019 mSv·mGy –1·cm (Table 1)61. The conversion factor is applicable to CT of the 
head and eﬀective dose is calculated according to the International Commission on 
Radiological Protection 103 publication62. 
Table 1   Acquisition and reconstruction parameters on two cone-beam computed 
tomography (CBCT) and two multi-slice computer tomography (MSCT) imaging 
systems. Associated eﬀective dose values are shown for the acquisitions. 
CBCT MSCT
iCAT ILUMA Aquilion 64 Sensation 64
Acquisition parameters
   Tube voltage (kVp) 120 120 120 120
   Tube current (mA) 47 (pulsed) 3.8 (continuous) 200-100-50-25-10 139-69-35-17-15* 
   Rotation time (s) 40 40 0.5 1
   Beam collimation (mm) 1 x 60 1 x 60 4 x 0.5 12 x 0.6
   Pitch n.a. n.a. 0.75 0.45
Reconstruction parameters
   Kernel FC84 U95u
Radiation dose
   Eﬀective dose (mSv) 0.04 0.10 0.63-0.32-0.16-
0.08-0.03
0.63-0.32-0.16-
0.08-0.07*
* The lowest eﬀective dose on the Aquilion 64 was 0.03 mSv (tube current 10 mA), however, the Sensation 64 did 
not allow scanning at this eﬀective dose value. The lowest eﬀective dose for the Sensation 64 was 0.07 mSv (tube 
current 15 mA)
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Statistical analysis
Friedman’s ANOVA was used to test for diﬀerences in image quality ratings between 
protocols. In case of a significant overall eﬀect, post-hoc comparisons were performed 
with Wilcoxon signed-rank test (with Bonferroni correction). We completed three analyses 
for each aspect of image quality:
a) Routine clinical CI protocols for all systems (i.e. CBCT protocols versus higher-dose 
Sensation 64 [309 mAs] and Aquilion 64 [100 mAs] protocols). Wilcoxon test significant 
at p = 0.008.
b) Routine clinical CI protocols for the CBCT systems and dose-matched protocols for 
MSCT (i.e. the ILUMA protocol was compared with the 39 mAs Sensation 64 and the 12 
mAs Aquilion 64 protocol). Wilcoxon test significant at p = 0.017.
c) Analysis of the eﬀect of decreasing dose for MSCT scans (4 lower dose protocols versus 
the clinical CI protocol per MSCT system). Wilcoxon test significant at p = 0.013. 
Spearman correlation was used to test for correlation between the rated variables and 
radiation dose.
Inter-observer agreement was evaluated using the mean linear-weighted kappa calculated 
from the six possible observer-combinations per variable. Kappa values < 0.20 indicate 
poor agreement; 0.21 - 0.40 fair agreement; 0.41 - 0.60 moderate agreement; 0.61 - 0.80 
good agreement; and values 0.81 - 1.00 very good agreement64
2.3.  Results
Temporal bones
CT revealed scala vestibuli position of several contacts in one temporal bone. Full, 
uncomplicated insertion was achieved in all other temporal bones.
Dosimetry
The CTDIw was measured for the CBCT acquisitions (i.e. 3.7 mGy for the iCAT and 8.6 mGy 
for the ILUMA). Normalized CTDI was measured for clinical MSCT acquisitions (i.e. 15.4 
mGy/100 mAs for the Sensation 64 and 41.99 mGy/100 mAs for the Aquilion 64). Table 2 
lists the eﬀective doses.
Spatial resolution
Spatial resolution of the systems expressed by the full width at half-maximum (FWHM) of 
the PSF are listed in Table 3. For CBCT systems, longitudinal FWHM was lower than in-plane 
FWHM whereas MSCT systems showed lower in-plane FWHM (see table). Diﬀerences were 
also found within modalities: the maximum diﬀerence within CBCT systems was 43% and 
within MSCT systems was 29%. The best spatial resolution was found with ILUMA.
stored and used by all observers for image quality assessment. Observers were allowed to 
change the predefined window setting. 
 MPRs were presented in random order to four observers (blinded to scanner type 
and dose-level information): a head and neck radiologist with 11 years of experience, a 
physicist with 5 years of experience, an otologic surgeon with 16 years of experience and 
an ENT resident surgeon with 3 years of experience in temporal bone imaging. Observers 
evaluated six aspects of image quality (visualization of electrode position, electrode 
contacts, osseous spiral lamina and cochlear walls, presence of artifacts and overall 
impression of scan quality) in A, B or D planes on a 5-point scale ranging from 0 (very poor 
quality) to 4 (very good quality) (Appendix 1).
Figure 1  Example of multi-planar reconstruction used for the image quality assessment. 
One plane perpendicular to the mid-modiolar axis (D) with four quadrants defined using a crosshair 
with its origin on the mid-modiolar axis and the x-axis through the center of the round window and 
two additional planes perpendicular along x-axis (A) and y-axis (B). The tip of the electrode is often 
placed in the same quadrant as the basal portion. Electrode contacts placed beyond the fourth 
quadrant are referred to as located in the fifth or eventually sixth quadrant.
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Image quality ratings
Mean ratings over all observers per protocol and mean kappa values are listed in Table 2. 
Fig. 2 gives an impression of the inter-observer variability by showing the mean ratings of 
overall image quality of the clinical protocols per observer. Based on the kappa values, the 
inter-observer agreement for ratings on the visibility of individual electrodes was good; 
agreement for other variables was fair to poor.  
 Quadrants of the cochlea were rated separately for the identification of individual 
electrode contacts to analyze potential diﬀerences due to the diminishing spacing 
between the contacts. For the statistical analysis, we used the mean score pooled over all 
quadrants because diﬀerences between quadrants were similar across systems. 
The osseous spiral lamina was not visible or was only vaguely visible in all acquisitions 
(mean score over all acquisitions and observers was 0.06). No statistical diﬀerence was 
found between any of the protocols for this variable and there was no correlation with 
protocol radiation dose. 
Clinical CI protocols
Although there was no main eﬀect of system type (MSCT or CBCT) on identification of 
individual electrode contact ratings, there were significant diﬀerences between systems. 
Results showed that both the ILUMA and Sensation 64 allowed all electrodes to be 
distinguished from adjacent electrodes (separate at the outer edges and/or fully separate, 
mean rating ≥ 2). The remaining two systems were reported as only allowing visualization of 
some individual electrodes (iCAT) or almost no individual electrodes (Aquilion 64), Fig. 3). 
Visibility of cochlear walls and overall image quality was rated higher on MSCT than on 
CBCT systems. Although the inner and outer cochlear wall were vaguely or clearly visible 
over their entire length with all systems (mean rating ≥ 2), both MSCT systems had a 
significantly higher rating on outer wall visibility than ILUMA and one MSCT system 
(Aquilion 64) had a significantly higher rating than iCAT. 
 Overall image quality of the CBCT scans was rated poor to suﬃcient whereas the 
MSCT scans were rated suﬃcient to good. Only a significant diﬀerence was found between Ta
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Table 3   Point Spread Function (PSF) measurements per scanner. FWHM: full width at half 
maximum of the PSF curve. 
Variable FWHM (in mm)
iCAT ILUMA Aquilion 64 Sensation 64
In-plane 0.75 0.43 0.68 0.48
Longitudinal 0.52 0.39 0.81 0.70
Ratio in-plane/longitudinal 1.44 1.10 0.84 0.69
26 | Chapter 2 Cone-beam versus multi-slice computed tomography | 27
Sensation 64 and iCAT. No clear diﬀerence in scalar localization and artifacts was found 
between MSCT and CBCT systems. 
 Determination of the scalar localization did not significantly diﬀer between any of 
the systems. For all scans, it was possible to determine the scalar localization of 50-75% 
of the electrode array (mean rating 2-3). All protocols resulted in mild to medium artifacts 
with a low eﬀect on image evaluation (mean rating 2-3) with Aquilion 64 significantly 
outperforming iCAT.
a) Dose-matched protocols
Identification of individual electrodes had the same pattern of results as the ‘Clinical CI 
protocols’. For all other image quality variables, there was no clear diﬀerence between 
MSCT and CBCT systems (Fig. 4). 
Unlike in the comparison of clinical protocols, the CBCT allowed now similar or better 
visualization of the inner wall than MSCT. 
Within the MSCT systems there was a significant between-system diﬀerence. The Aquilion 
64 was rated as having better visualization of the inner and outer wall and scalar localization 
than the Sensation 64. 
Figure 2  Bar chart of mean ratings per observer of the overall image quality of the clinical 
CI protocols with standard deviation.
0 
1 
2 
3 
4 
Observer 1 Observer 2 Observer 3 Observer 4 
iCAT 
ILUMA 
Toshiba 
Siemens 
Figure 3   Images of clinical-dose protocols of the same specimen.
Upper left: Sensation 64 (0.64 mSv), upper right: Aquilion 64 (0.64 mSv), bottom left: iCAT (0.04 mSv), 
bottom right: ILUMA (0.10 mSv).
Figure 4   Images of dose-matched protocols of the same specimen. 
Upper row (from left to right): ILUMA (0.10 mSv), Sensation 64 (0.08 mSv) and Aquilion 64 (0.08 
mSv), bottom row: iCAT (0.04 mSv), Sensation 64 (0.07 mSv) and Aquilion 64 (0.03 mSv).
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correlated with speech perception66. Scalar localization is important because electrode 
insertion into the scala vestibuli negatively aﬀects speech perception66,67 and the traversing 
of an array from scala tympani to scala vestibuli is an indirect sign of damage to the 
osseous spiral lamina. The distance between electrode contacts and the inner cochlear 
wall is thought to be another important factor in speech perception results although 
evidence is sparse68,69 and several authors report no clear correlations70-72.
To adequately determine insertion depth, it is necessary that scans are not heavily aﬀected 
by artifacts and that the position of the round window can be assessed (directly or 
estimated on the basis of the semicircular canal and vestibule55,73). Our results show that 
determining insertion depth is possible with the CBCT and the low-dose MSCT systems 
used in this study. For the assessment of scalar localization, we found no significant 
diﬀerences between CT systems. As we also found no general eﬀect of radiation dose on 
scalar localization. Thus, for the MSCT systems, lowering radiation dose to a level that still 
ensures a suﬃcient overall image quality may be considered. Although some authors 
report that the osseous spiral lamina is directly visible on postoperative scans50,52, this was 
not possible with any of the systems in our study.
 To directly measure the distance between the electrodes and cochlear walls, both 
the individual electrode contacts and the inner cochlear wall need to be visualized. The 
visibility of individual electrodes depends on the intercontact distances. With distances 
ranging from 0.8 to 0.4 mm between electrode contacts, the CIs used in this study are the 
smallest currently on the market. The ILUMA reached the required spatial resolution to 
allow contacts to be distinguished and the Sensation 64 scanner also allowed visualization 
of individual electrodes. For CI’s with larger intercontact distances (e.g. arrays consisting of 
12 and 16 contacts) all scanners would have suﬃcient spatial resolution for visualizing 
individual contacts. As our results demonstrate, outcomes are system-dependent and are 
not influenced by radiation dose. Therefore, a system with low radiation dose and spatial 
resolution that can at least resolve the inter-electrode distance should be used when 
determining the position of individual electrodes. Visualization of the inner and outer 
cochlear walls was in most cases better with clinical MSCT protocols than with CBCT 
protocols. In our study, dose-matched MSCT protocols had comparable ratings of inner 
and outer wall visibility and overall image quality with CBCT. 
 Therefore, both CBCT and MSCT can be used for measuring the distance between 
electrode contacts and the cochlear walls as long as the system has suﬃcient resolution 
to allow visualization of individual contacts. For MSCT devices, this should be done with 
the minimum radiation dose required for adequate visualization of the cochlear walls.
Overall image quality appears related to radiation dose. Clinical MSCT protocols were 
rated as having better image quality than CBCT protocols (although only significant for 
the comparison between Sensation 64 and iCAT) whereas the dose-matched MSCT 
b) Eﬀect of decreasing dose for MSCT protocols
Three image quality variables were negatively aﬀected by reducing the radiation dose: 
the visibility of the cochlear inner and outer wall and the overall image quality (Friedman 
ANOVA and Spearman correlation p < 0.05). Inner and outer wall visibility was significantly 
reduced in comparison with clinical dose protocols when the tube charge was reduced to 
39 mAs with the Sensation 64 and to 5 mAs with the Aquilion 64. The overall image quality 
rating for the Sensation 64 scans was significantly reduced (to below 2 [suﬃcient]) when 
the tube charge was reduced to 77 mAs. With the Aquilion 64, ratings of image quality 
were stable (around 2) until the tube charge was reduced to an ultra low dose level of 
5 mAs when image quality significantly decreased. There was no eﬀect of radiation dose 
on observers’ ratings for identification of individual electrodes. Reducing radiation dose had 
a negative eﬀect on scalar localization for the Sensation 64 system: 39 mAs resulted in 
significantly lower ratings compared to 309 mAs. For the Aquilion 64, there was no clear 
eﬀect of radiation dose and there was no significant overall correlation between radiation 
dose and scalar localization ratings.
 For the Sensation 64 system, reducing the radiation dose significantly reduced the 
amount of artifacts (Friedman’s ANOVA, p < 0.05). The 33 mAs protocol had significantly 
fewer artifacts than the 309 mAs protocol. For the Aquilion 64 system, no eﬀect of 
radiation dose on artifacts was found.
2.4.  Discussion
In this study we compared two CBCT systems with two MSCT systems for evaluating 
visualization of a 22-electrode contact CI. Our results show that CBCT is adequate for post- 
operative CI imaging compared to clinical MSCT protocols. There are, however, diﬀerences 
in spatial resolution and perceived image quality between manufacturers’ systems48. 
Moreover, CBCTs lack the flexibility of MSCT systems on acquisition and reconstruction 
parameters (e.g. tube voltage, tube current, reconstruction kernel, slice thickness and slice 
interval). We have shown that dose reduction on MSCT can be achieved to a dose level 
similar to CBCT with an image quality comparable to CBCT. In most cases we found that 
image quality depends on scanner specific features but visualization of the inner and 
outer cochlear wall and the overall image quality depend on radiation dose. 
In the clinical setting CT may be useful for evaluating intracochlear trauma or for frequency 
mapping in selected cases. Postoperative imaging is also used in research on the 
relationship between the intracochlear electrode array position and speech perception 
results and is an essential tool for evaluation of new electrode array designs. The insertion 
depth (or angle) of the most apical and/or basal electrode is of interest because deep 
insertion may be associated with trauma65 and insertion depth may be (negatively) 
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protocols were rated similar to CBCT protocols. These findings contrast with the only other 
study comparing a commercially available CBCT system (MiniCAT, Xoran Technologies, 
Ann Arbor, USA) with a 64-slice CT in which the subjective image quality of the CBCT was 
rated significantly higher on an ordinal 5-point scale. However, there were no significant 
diﬀerences in measurements of electrode to modiolus distance between CBCT and MSCT 
and intracochlear array evaluation correlated well with histological evaluation for both 
techniques56. Other performance studies on CI evaluation with CBCT scanners have not 
compared results with MSCT systems, but report reliable measurements of electrode 
positions51,53,55.
Our study has some limitations. First, we had no access to complete cadaver heads and 
had to resort to temporal bones. Several studies have used temporal bones for image 
quality assessment41,46,47,49,50,52-54,56,57 but this disregards the radiation absorption of a human 
skull, which may result in larger electrode artifact43. To mimic clinical conditions, we 
created a human skull phantom; preliminary test revealed that there was a considerable 
diﬀerence in image quality between scans of the phantom and of a temporal bone. 
Second, the inter-observer agreement of the rating of most variables was fair to poor, 
which may partially be explained by the fact that the observers have diﬀerent backgrounds. 
Nevertheless, all have (varying) experience with otologic CT imaging and were trained by 
the involved radiologist before rating the images. Fig. 2 displays that although there are 
diﬀerences in rating of the clinical protocols between observers, there is considerable 
agreement on the ranking of the scanners. 
2.5.  Conclusion
Our study shows that both CBCT and MSCT are adequate tools for low-dose postoperative 
cochlear implant imaging. However, performance diﬀerences within CBCT and MSCT 
systems exist and should be taken into account when choosing an imaging modality, 
depending on required information for clinical issues or research questions.
Appendix 1   Ordinal scales used for the image quality assessment. 
Visualization of single electrodes per quadrant
0 - No electrodes distinguishable
1 - Some electrodes separate from adjacent electrodes at the outer edges
2 - All electrodes separate from adjacent electrodes at the outer edges but none fully separate
3 - Some electrodes fully separate from adjacent electrodes
4 - All electrodes fully separate from adjacent electrodes
Visualization of electrode position (relative to the osseous spiral lamina)
0 - Electrode position cannot be determined
1 - ~25% of electrode positions can be determined
2 - ~50% of electrode positions can be determined
3 - ~75% of electrode positions can be determined
4 - All electrode positions can be accurately determined
Visualization of osseous spiral lamina
0 - Not visible
1 - Vaguely visible at the modiolar side
2 - Clearly visible at the modiolar side
3 - Vaguely visible over the entire width
4 - Clearly visible over the entire width
Visualization of cochlear inner/outer wall
0 - Not visible
1 - Vaguely visible in basal part of the cochlea or at other level than that of the array
2 - Vaguely visible over entire length
3 - Clearly visible at basal or non-implanted part and vaguely at the rest
4 - Clearly visible over entire length
Presence of artifacts
0 - Severe artifacts render image evaluation impossible
1 - Severe artifacts heavily aﬀect image evaluation
2 - Mild artifacts with some eﬀect on image evaluation
3 - Some artifacts without eﬀect on image evaluation
4 - No artifacts
Overall scan quality
0 - Very poor
1 - Poor
2 - Suﬃcient
3 - Good
4 - Very good
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3.1.  Introduction 
There is a growing demand for quality assessment in medicine. Outcome indicators that 
can be used are: patient satisfaction, quality of life, mortality and complications. Therefore, 
uniform registration and classification of complications is essential in order to compare results 
between medical centers. The shared responsibility for the registration of complications 
lies with the medical centers and the medical personnel. The key to successful complication 
registration is to create the infrastructure that warrants an easy, fast and safe means of 
recording.
 Moreover, strict registration of negative outcomes is necessary for the evaluation of new 
surgical procedures and new devices and also for determining the best policy regarding 
other management options, such as the necessity of postoperative antibiotic therapy. 
 Fortunately, severe complications in cochlear implant patients are rare. Therefore, 
a large number of patients is needed to detect statistical significant diﬀerences in 
complication rates between groups, which can be accomplished by pooling data from 
diﬀerent clinics if all the involved centers would be able to use the same system for 
registration of negative outcomes. 
 A distinction must be made between complications, sequelae and failures. Complications 
are unexpected events not intrinsic to the procedure, whereas sequelae are inherent to 
the procedure, both adding new problems to the underlying disease. Failures are events 
in which the purpose of the procedure is not fulfilled74. In case of cochlear implantation, 
the procedure itself may be a failure (i.e. a correctly functioning device is implanted 
without benefit for the patient) or the device itself may be malfunctioning. These device 
failures are further divided in ‘hard failure’ (a device with characteristics outside the 
manufacturer’s specification resulting in a loss of clinical benefit) and ‘soft failure’ (a device 
malfunction is suspected but cannot be proven using currently available in-vivo methods). 
Furthermore, a device may have measured characteristics outside the manufacturer’s 
specification, but still be of benefit to the patient75,76.
 It is also important that a similar definition of a complication is used. In literature, 
several definitions are used. Clavien and Dindo define a surgical complication as “any 
deviation from the normal postoperative course” (including asymptomatic complications)74,77. 
Rombout et al. define complications in otologic surgery as “incidents that are not intrinsic to 
the surgical procedure and that have a potential or actual negative eﬀect on surgical outcome 
or postoperative morbidity”78. These are very broad definitions that leave room for discussion 
on what is a complication and what is not. 
 We adopted the stricter definition of a complication that is given by the Dutch Order 
of Medical Specialists: “an unintended and unwanted event or condition during or following 
medical specialist treatment that is so detrimental for the health of the patient that adjustment of 
the medical treatment is necessary or that causes irreversible damage”79. This event has to take 
place during a period from the start of treatment that has been set by the Dutch ENT 
Abstract
The objective of this study was to create a system for uniform registration and classification 
of complications and failures in cochlear implantation and apply it to all patients who 
underwent implantation in our clinic. A definition for a medical complication was established 
and data from all cochlear implantations between 1987 and 2012 was entered into a 
custom-made database system. In 19.0% of more than 1,000 cochlear implantations, 
one or more medical complications were registered; the incidence of hard failure was 
2.3%. We found a decrease in device failures over the years and a constant rate of medical 
complications. Our database system, which is available free of charge, enabled fast and 
accurate data entry. We found a relatively high number of (minor) complications in our 
series, but comparison with literature is diﬃcult. This stresses the need for a uniform 
definition and classification system for complications in cochlear implant surgery.
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association at 6 weeks, but in order to include all possible cases of meningitis and device 
breakdown may occur at a later instant, we use the criterion that the event “is (probably) 
the result of, or has adverse consequences for the implantation”. 
 There are also several classification systems that have been used to report complications. 
For cochlear implantation, Cohen and Hoﬀman made the distinction between major and 
minor complications: major complications require additional surgery and/or hospitalization 
for treatment, while minor complications are treated expectantly and/or with medication 
alone80. A more widely used system in general surgery is the Clavien classification (adapted 
by Rombout et al. for otologic surgery78), which has later been modified into the Clavien- 
Dindo classification74,77. This system uses 5 grades based on patient morbidity: 
Grade I: requiring no/simple measurements (including anti-emetics, antipyretics, analgesics, 
diuretics, electrolytes and [bedside] seroma drainage)
Grade II: requiring pharmacological therapy (including blood transfusions and total 
parenteral nutrition)
Grade III: requiring surgical or radiological intervention
Grade IV: requiring IC/ICU management (life-threatening)
Grade V: death
The suﬃx “d” (for “disability”) is added when the patient suﬀers from a complication at the 
time of discharge.
In this paper we present the complications and failures of more than 1000 cochlear 
implantations, which were registered in a custom database that enables fast and accurate 
data entry, and grading of medical complications by diﬀerent classification systems. 
   
3.2.  Materials and methods
For data-entry, we created a Microsoft Oﬃce Access 2007 (Redmond, WA, United States) 
database (fig. 1). This is a relational database, which means that any number of implantations 
could be linked to a patient and any number of complications could be linked to an 
implantation (fig. 2).
 In order to make the system user-friendly and to allow fast and uniform data entry, we 
created forms with input masks (e.g. for dates) and lookups (a list of preset choices).  
 For instance, a list of the most common complications in cochlear implantations 
reported in literature, hard failure and symptoms of soft failure75 was composed (table 1). 
To further prevent bad data entry, we implemented required fields and several validation 
rules (e.g. date of a complication could not be before the date of implantation).
 To enable easy classification of the medical complications, we described the 
consequences of a complication in such a way that both the diﬀerence between ‘major’ 
Figure 1  Screenshot from data entry into the database.
Figure 2   A relational database system.
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deep vein thrombosis of the leg; there were no peculiarities during surgery. The second 
patient had pseudomonas meningitis; during surgery, inner ear malformation (Mondini 
dysplasia) resulted in perilymphatic gusher. The third patient had pneumococcal meningitis; 
during surgery, extensive CSF leakage had been found at several locations in the middle 
ear, necessitating obliteration of the ear (her hearing loss had also been the result of 
2 previous episodes of meningitis). The latter two patients had had pneumococcal 
vaccination before the occurrence of meningitis, the first had not.
and ‘minor’ complications could be made and the Clavien-Dindo grading system could 
be applied. Also, general patient data, such as the etiology of deafness, pneumococcal 
vaccination and several general risk factors for surgical complications (e.g. diabetes) could 
be registered.
 We built-in an export function that creates an anonymized copy of the database 
that can be used for analysis by other personnel than the cochlear implant team. By using 
one-way encryption with a secure hash algorithm (SHA-1), each patient is given a code 
based on name, birthdate and gender that makes identification of the patient impossible 
but allows for identification of double entries. This function, in combination with the 
uniform data entry, also enables the pooling and comparison of data from multiple 
implant centers.
 Data from all cochlear implantations between 1987 and 2012 was entered into the 
database. The majority of the data was entered retrospectively based on the patients’ 
charts and from the start of the project, data from new implantations was entered 
prospectively by members of our cochlear implant team.
3.3.  Results
Patient characteristics
The first cochlear implantation in Nijmegen took place in 1987. Between 1987 and 2012, 
912 patients underwent a total of 1003 implantations, 470 women and 442 men. Mean age 
at implantation was 32.5 years (range 0.6-87.6 years), mean follow-up time was 8.6 years 
(range 1.9-26.8 years). Onset of deafness (best ear) was congenital in 275 cases (30.2%),  pre- 
lingual (< 3rd year) in 165 cases (18.1%) and post-lingual in 392 cases (43.0%). In 53 cases 
(5.8%) onset of deafness was at an early age, but it could not be determined whether this 
was pre- or post-lingual and 27 cases (3.0%) were not deaf at time of implantation (Fletcher 
Index < 90 dBHL). The latter group were patients with severe hearing loss who were 
implanted based on their speech perception scores (2 patients received an electro-acoustic 
system); the majority (22 cases) was also deaf at the other ear. 
Medical complications
In 191 implantations (19.0%), one or more complications were registered, 208 in total: in 
176 implantations (17.5%) one complication occurred during or after implantation, and in 
16 cases (1.6%) 2 complications occurred. Of these, 35 were intraoperative and 173 were 
postoperative. Forty-eight (23%) were classified as ‘major’ and 160 (77%) as ‘minor’ 
complications. The list of complications graded by the Clavien-Dindo classification is 
displayed in table 2. 
 There were 3 cases with postoperative meningitis (0.3%): the first patient was admitted 
with pneumococcal meningitis, herpes simplex infection, pseudomonas septicemia and 
Table 1   The list of complications included in the database. 
Description Type Intra/Postoperative
Device breakdown Hard failure Postoperative
Declining/intermittent performance Soft failure
Aversive auditory symptoms 
Facial nerve stimulation 
Other aversive non-auditory symptoms
Seroma Medical
Hematoma
Wound infection
Skin flap problems
Traumatic/pressure skin lesion
Acute otitis media
Mastoiditis
Meningitis 
CSF leak
Vertigo
Chorda tympani dysfunction
Facial nerve dysfunction
Magnet displacement
Electrode array dislocation
Electrode extrusion
Allergy/rejection 
Pain
Tinnitus
Cholesteatoma
Misplaced electrode array Intraoperative
Chorda tympani lesion
Facial nerve lesion
CSF leak
Other Intra-/Postoperative
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There was 1 case of facial nerve dysfunction (House-Brackmann grade 3), which occurred 
2 weeks after implantation on the implanted side and therefore might be unrelated (Bell’s 
palsy). Patient was treated with famciclovir and oral steroids and recovered fully.  
 There were 8 cases of CI explantation due to a medical complication: 3 cases of a 
severe wound infection, 2 cases of a misplaced electrode array (1 in hypotympanum and 
1 tip-foldover), 1 case of electrode extrusion, 1 case of electrode dislocation and 1 case of 
CSF leak with subsequent wound infection after closure of the leak had been attempted. 
Device failures
There were 23 cases of hard failure (2.3%), in 2 cases this was after a trauma. All devices 
were explanted. Of the patients with soft failure, there were 7 with severe facial nerve 
stimulation; 1 patient had re-implantation and 1 patient underwent cochlear implantation 
in the other ear. One patient became a non-user and in other cases a substantial number 
of electrodes could not be used. Other cases of soft failure included two patients with 
pain when the CI was switched on and 3 cases of declining performance, in 2 of which the 
CI was explanted and in the other case a CI was implanted in the other ear.
 When complication and device failure rate were calculated per 5 years, we found a 
significant decrease in device failures over the years (Χ2 (4) = 53.64, p < .001), while the 
incidence of medical complications remained fairly constant (no significant diﬀerence 
between 5-year periods) (Fig. 3).
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Figure 3   Complication and failure rates per 5 years of cochlear implantation.
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technological development. However, there may be some overestimation because the 
older devices have had a longer follow-up. 
3.5.  Conclusion
The benefits of using a database system were already acknowledged by Ray et al., who 
were the first to describe the use of a computerized database system for registering 
cochlear implant data86. The advantage of using the present database system is that it not 
only enables fast and accurate data entry, but also makes it easier to combine and compare 
results from diﬀerent medical centers. This is particularly useful in comparing diﬀerent 
surgical techniques and studying complications with a low incidence and high morbidity 
(such as meningitis). Therefore, we make this database freely available (database and 
manual can be downloaded at http://bit.ly/cidatabasenijmegen). Nevertheless, every 
complication registration system depends on consequent data entry by the surgeon or 
other members of the cochlear implant team.
 In our series we found a relatively high number of complications in cochlear implant 
surgery that has been stable over the years, while the number of device failures has 
declined. This stresses the use of a uniform definition and classification system for 
complications in cochlear implant surgery, not only to fairly compare results but also for 
investigating means for reducing these complications. 
3.4.  Discussion
Complication registration is important for both quality assessment and research purposes 
and a uniform definition and classification is essential for comparison of complication data. 
The custom database we created for this purpose enables fast and accurate data entry 
and the use of the most frequently used classification systems for surgical complications. 
 In our series, medical complications occurred in 19.0% of implantations. Incidence of 
complications reported in literature ranges from 6 to 63%37-39,81,82.
 There are possible explanations for the relatively high number of complications in 
our series: 
 The first reason is that the bulk of our data was obtained by extensive reviewing of 
medical charts. More than three-quarters of our complications was considered as ‘minor’ 
(such as seromas or hematomas) and it is plausible that a number of these would not have 
been registered as complications in clinical practice.
 The second reason is the definition we used, which states that every event that 
leads to adjustment of the medical treatment is considered a complication. Thus, if any 
non-routine medication were prescribed (for instance antibiotics for minor redness of the 
wound), this would be registered as a complication (in this case a wound infection). In our 
experience, there is a low threshold for prescribing antibiotics in cochlear implant patients 
for most physicians because of the fear of infection around the implant or even meningitis 
(in many other countries, postoperative antibiotics are given routinely). This may (partially) 
explain the high number of wound infection in our series, especially given the fact that 
the majority was resolved with pharmacological treatment alone (grade II). In many of the 
aforementioned studies, no definition of a complication was given.
 Third, the most frequent complication we encountered was a lesion or dysfunction of 
the chorda tympani nerve. It can be debated whether all these cases should be considered 
as a complication, especially since in at least a quarter of the cases the chorda was 
intentionally sacrificed to gain access to the cochlea and in only 22.5% of these cases there 
was a reported loss of taste for a prolonged period. Furthermore, loss or alteration of taste, 
decrease in tongue sensation or, less common, xerostomia are no longer present in 94% 
to 96% of patients where the chorda tympani nerve was cut, 2 years after surgery. Electro-
gustometry thresholds, on the other hand, often remain elevated83,84, thus making it an 
unintended and unwanted event with permanent damage. Patients may also underreport 
persistent loss or alteration of taste and physicians may not always inquire about taste loss 
after surgery. 
 On the other hand, several authors included device failures in the total number of 
complications, which made the rate of actual medical complications lower. 
 The failure rate (hard and soft failure) in our series was 3.5%. This is comparable to the 
failure rate of 3.79% that was reported in a large multicenter study of 12,856 devices85. We 
found a decrease in device failures over the years, which is probably the result of 
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4.1.  Introduction
Cochlear implantation is very successful in restoring hearing in patients with profound 
sensorineural hearing loss, but surgical complications are reported in 6-63% of the cases37-39,81,82. 
This complication rate is comparable to that of active middle ear implantation (16-21%87,88), 
but is higher than in other fields of otology such as cholesteatoma surgery (6-17%, 
although reports are sparse89,90). 
 The first step in reducing these complications is identification of the most common 
and most severe complications. Although there are many reports on complication rates, 
these results are hard to compare, since there is no consensus on reporting them (except 
for meningitis91 and device failure92,93). Hansen et al. have proposed a useful overview of 
definitions and criteria, which was elaborated by Jeppesen et al.39,82, but unfortunately, 
this has not yet been widely used. Similar problems arise with classification: most studies 
diﬀerentiate between major and minor complications, but the use is inconsistent and a 
clear definition is rarely given. Hansen et al. have also addressed this problem, but their 
definition still leaves room for interpretation (e.g. ‘a significant medical problem’ is 
considered a major complication). To tackle this problem in general surgery, Clavien et al. 
developed a classification system (modified by Dindo et al), based on the therapy used 
to treat the complication.94,95 Previously, the authors have used this Clavien-Dindo system, 
in combination with a custom-made database system, to classify complications in cochlear 
implant surgery.96
 The second step is the identification of risk factors. In contrast to reports on 
complication rates, there are very few reports on this subject, mainly concerning meningitis97 
and wound infection.98,99 Again, a uniform registration of complications is necessary in 
order to make a fair comparison between diﬀerent treatment modalities. And especially 
since some (serious) complications are rare, this can only be achieved by pooling data 
from diﬀerent studies.
 The aim of this study was to not only give an overview of device failures and medical 
complications in over 1,300 cochlear implantations, but to also identify risk factors and 
find ways to reduce the number of complications.
4.2.  Materials and methods
Data from all cochlear implantations between January 1st 1987 and January 1st 2015 were 
entered in a custom-made Microsoft Oﬃce Access (Redmond, Washington, USA) database 
(freely available: http://bit.ly/cidatabasenijmegen).96 The majority of data were entered 
 retrospectively from the patients’ charts, but implantations and complications occurring 
after the start of the project were entered prospectively by members of the cochlear 
implant team. Patient demographics, pneumococcal vaccination status and possible risk 
Abstract
The objective of this study was to achieve uniform reporting of complications and failures 
in cochlear implantation, to analyze complications and failures and to identify risk factors 
for complications in a series of over 1,300 cochlear implantations. Data from all cochlear 
implantations from 1987 to 2015 were retrospectively and/or prospectively entered in a 
custom-made database. Complications were classified using the Clavien–Dindo system 
and risk factors were identified by statistical analysis. A complication rate of 18.4% and a 
device failure rate of 2.9% was found. There was a higher rate of hematoma in patients 
with a clotting disorder and when a subtotal petrosectomy was performed, a higher rate 
of wound infections in patients who were not vaccinated against Streptococcus pneumoniae 
and a higher rate of meningitis in patients with an inner ear malformation. The use of 
a strict definition of a medical complication and device failure - in combination with 
the Clavien-Dindo classification system - enables uniform and objective registration of 
adverse events and prevents any tendency to down-grade complications. Complication 
and failure rates in this series are comparable to those reported in literature. These results 
stress the need for pneumococcal vaccination, which may prevent general wound 
infections, but is especially important for patients with inner ear malformation, who have 
an increased risk of (postoperative) meningitis.
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 The definition of a device failure was based on the European consensus on implant 
failures93 and the soft failures consensus92: hard failure is a device with characteristics outside 
the manufacturer’s specification resulting in a loss of clinical benefit and soft failure is a device 
with characteristics within the manufacturer’s specification, but with unexplained declining 
performance or the occurrence of (non)auditory aversive symptoms such as atypical tinnitus, 
facial nerve stimulation or a popping or shocking sensation.
 Pearson’s chi-square test was used to test the relationship between possible risk 
factors and the occurrence of certain complications. If multiple risk factors were tested for 
one complication, a loglinear analysis was done instead. If the number of events was small, 
Fisher’s exact test was used, with a Bonferroni correction to adjust the p-value used as 
criterion for significance. IBM SPSS Statistics version 22.0 (Armonk, New York, USA) was 
used for all analyses. 
4.3.  Results
Population
The first cochlear implantation in Nijmegen, the Netherlands, took place in 1987. Up to 
2015, 1222 patients (656 women and 566 men) underwent a total of 1362 implantations 
(527 in children and 835 in adults). Mean age at implantation was 34.8 years (range, 0.6- 
87.6 years). Mean follow-up time was 7.9 years (range, 0.1-27.2 years; follow-up time for 
some implantations was less than one year because of device failure or patients lost to 
follow-up).
Complications
In 18.4% of the implantations (n=250), 1 or more complications were registered. In 224 
cases (16.4%) there was a single complication during or after implantation and in 26 cases 
(1.9 %) there were 2 complications; 276 complications in total. Forty-three (15.6%) of these 
complications occurred intra-operatively and 233 (84.4%) occurred post-operatively. 
Fifty-seven (20.6%) of these complications were classified as ‘major’ and 219 (79.3%) as 
‘minor’. Table 2 displays the total list of complications, classified by the Clavien–Dindo 
system. The only patient with a grade IV complication had a preexistent metabolic 
disorder and lactate acidosis that required ICU management. The category ‘other’ ranged 
from external otitis to urinary retention and delirium.
 The majority of postoperative complications (83.6%) occurred within 1 year after 
surgery (Fig. 1). Medical complications were equally common in adults as in children (18.2 
vs. 18.6% respectively, Pearson Chi2, p = 0.057).
factors for complications (such as smoking, immunodeficiency/-suppression, clotting 
disorder/anticoagulant use and inner ear malformation) were registered. Implantation 
data such as the device type, primary/revision surgery, skin incision, surgical approach 
(posterior tympanotomy or subtotal petrosectomy), antibiotic prophylaxis and intra- 
operative findings (such as middle ear inflammation) were recorded.
 The definition of a medical complication that was used, was based on the one 
provided by the Dutch Federation of Medical Specialists100 and the recommendations of 
Jeppesen et al.39: an unintended and unwanted event or condition during or following medical 
specialist treatment that is so detrimental for the health of the patient that adjustment of the 
medical treatment is necessary or that it causes irreversible damage; and is (probably) the result 
of, or has adverse consequences for the implantation. A period of one year was considered a 
suﬃcient minimum follow-up time.
 The consequences of a complication were registered in such a way, that both 
 diﬀerentiation between ‘major’ (requiring additional surgery and/or hospitalization for 
treatment) and ‘minor’ complications was possible, and the use of the contracted form of 
the Clavien–Dindo classification system. This is a validated 5-scale classification system 
that is based on the treatment of the complication (Table 1).
Table 1  Contracted form of the Clavien-Dindo classification of surgical complications95. 
Grades Definition
Grade I Any deviation from the normal postoperative course without the need 
for pharmacological treatment or surgical, endoscopic and radiological 
interventions.
Acceptable therapeutic regimens are: drugs as antiemetics, antipyretics, 
analgetics, diuretics and electrolytes and physiotherapy. This grade also includes 
wound infections opened at the bedside.
Grade II Requiring pharmacological treatment with drugs other than such allowed for 
grade I complications. Blood transfusions and total parenteral nutrition are also 
included.
Grade III Requiring surgical, endoscopic or radiological intervention
Grade IV Life-threatening complication (including CNS complications*) requiring IC/ICU-
management
Grade V Death of a patient
Suﬃx ’d’ If the patient suﬀers from a complication at the time of discharge, the suﬃx 
“d” (for ‘disability’) is added to the respective grade of complication. This label 
indicates the need for a follow-up to fully evaluate the complication.
* brain hemorrhage, ischemic stroke, subarachnoidal bleeding, but excluding transient ischemic attacks; 
CNS: central nervous system; IC: Intermediate care; ICU: Intensive care unit
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Chorda tympani lesion/dysfunction
Ten patients reported taste disorder after surgery while the chorda tympani nerve was left 
macroscopically intact during surgery. In contrast, of the 34 patients in which the nerve 
was cut, only 4 patients reported taste disorder. In 19 of these patients, the chorda was cut 
intentionally. Overall, only 3 patients reported taste disorder several weeks after surgery 
(subsequent data were often unavailable).
Seroma
The majority of patients with seroma were treated by puncture aspiration and/or pressure 
bandage (one puncture was performed under general anesthesia), and some received 
additional antibiotics. There was no relationship between the occurrence of seroma and 
the type of skin incision, nor with the surgical approach. Seroma was more common in 
patients who smoked (6.1 vs. 2.3%), but the diﬀerence was not significant (Fisher’s exact 
test, p = 0.027).
Figure 1   Kaplan-Meier estimated survival function for medical complications.
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Despite the low frequency of meningitis, an attempt was made to identify risk factors. No 
relationship between vaccination against Streptococcus pneumoniae, immunodeficien-
cy/-suppression (total n=12) and the occurrence of meningitis was found. Nor did there 
prove to be a relationship between middle ear inflammation at the time of implantation 
(total n=66) and meningitis (1.5 vs. 0.2%, Fisher’s exact test, p = 0.139). There was, however, 
a significant association between inner ear malformation (total n=87) and the occurrence 
of meningitis (2.3 vs. 0.1%, Fisher’s exact, p = 0.012).
Facial nerve lesion
One patient had a transient facial nerve dysfunction (House-Brackmann grade III) 19 days 
after surgery. He was treated with prednisone and famciclovir and fully recovered. A 
4-year-old child with obliterated cochleae had a facial nerve paresis directly after surgery 
(House-Brackmann grade III). She underwent revision surgery and the electrode array 
proved to be in contact with a dehiscent part of the facial nerve. It was lifted of the nerve 
and fixated, resulting in full recovery of symptoms.  
Device failures
There were 40 cases of device failure (2.9%): 27 cases of hard failure (2.0%) and 13 cases of 
soft failure (1.0%). Failures per device type are listed in table 3. The mean time to device 
failure was 5.4 years. The majority of soft failures consisted of facial nerve stimulation (n=7): 
one patient was reimplanted, one was implanted in the other ear, one became a non-user 
and in the other patients the mapping had to be significantly adjusted. Facial nerve 
stimulation was significantly more common in patients with otosclerosis (total n=36; 5.6 
vs. 0.4%, Fisher’s exact test, p = 0.013). Three patients experienced a decline in performance 
(2 were reimplanted and 1 was implanted in the other ear) and 3 patients experienced 
pain only when using the implant (1 was explanted, in 1 case the tympanic nerve was cut 
[resulting in minimal improvement] and in the other case the patient mainly used his 
other CI).
Explantations
Forty-seven patients (3.5%) underwent explantation of their CI. In the majority of cases 
(n=31), this was because of device failure (4 soft failures and 27 hard failures). Two patients 
who initially received a 3M/House or Vienna device were reimplanted with a multichannel 
device and two other patients requested explantation because of poor functional 
outcome. Twelve patients underwent explantation because of a medical complication: 6 
patients had a wound infection or dehiscence, 1 had a complicated posttraumatic CSF 
leak, there were 3 cases of dislocation of the electrode array and 2 patients had a misplaced 
electrode array (1 in hypotympanum and 1 tip-foldover). 
Hematoma
Hematomas were treated in the same manner as seromas. No association was found 
between the occurrence of hematoma and the type of skin incision, but hematoma (at 
the primary surgical site) was significantly more common when subtotal petrosectomy 
was performed (in patients with a radical cavity, n=15), compared to posterior 
tympanotomy (13.3 vs. 1.0%, Fisher’s exact test, p = 0.011). It occurred more often in 
patients with cardiovascular disease (3.4 vs. 0.9%), but this diﬀerence was not significant 
(Fisher’s exact test, p = 0.066). A significant correlation was found between the presence 
of clotting disorder or anticoagulant use, and hematoma: 5.1 vs. 0.9% (Fisher’s exact test, p 
= 0.009).
Pain
Chronic postoperative pain was more commonly found in recent years (not reported 
before 2004), but no correlation was found with the type of skin incision or device that 
was used. Nor did it matter whether it was primary or revision surgery. It was mostly 
treated with general or local anesthetics.
Wound infection
The majority of wound infections presented as superficial inflammation of the skin and 
were treated with oral antibiotics. There were 10 cases of major wound infection, 1 had a 
concurrent acute otitis media (mean time to infection was 60.7 days [range, 7-426 days]). 
Three of these patients were treated with intravenous antibiotics and the rest required 
surgical intervention, resulting in explantation in 4 cases. In one patient, the implant was 
preserved with the use of gentamicin-impregnated collagen sponges.101 No relationship 
was found between the duration of antibiotic administration (intraoperative, intra- and 
1-7 days postoperative or intra- and 8-14 days postoperative) and the occurrence of 
wound infections. An association with immunodeficiency/-suppression or middle ear 
inflammation (including otitis media with eﬀusion) during surgery was neither found, but 
there was a significantly higher rate of wound infections in patients who were not 
vaccinated against Streptococcus pneumoniae (5.7 vs. 2.6%, loglinear partial Chi2, p = 0.031). 
Meningitis
There were 3 cases of postoperative meningitis, occurring 0, 391 and 800 days after 
implantation. One case had a Pseudomonas aeruginosa infection and 2 had a Streptococcus 
pneumoniae infection. Of the latter, 1 patient had recurrent meningitis before implantation 
and had been vaccinated against Streptococcus pneumoniae, but later proved to have a 
specific antibody deficiency (the other patient had not been vaccinated at the time of 
meningitis). Two of the patients had an inner ear malformation: one patient had an 
incomplete partition type II (with a gusher during surgery) and the other an isolated 
enlarged internal auditory canal.
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4.4.  Discussion
In this series of 1362 cochlear implantations, a complication rate of 18.4% and a device 
failure rate of 2.9% was found. There is a large variation of reported complication rates in 
literature.37-39,81,82 Important factors are the definition of a complication that is used, the 
diﬀerence between retro- or prospective data collection, and whether or not to consider 
the (intentionally) cutting of the chorda tympani nerve and a device failure a medical 
complication.96 Use of the Clavien-Dindo classification system and the aforementioned 
strict definition of a complication prevents subjective interpretation of adverse events and 
any tendency to down-grade complications, because it is based on data that are usually 
well documented.102
 The main goal of this study was to identify risk factors for medical complications. 
Probably the best-known publication on this subject is by Reefhuis et al., who demonstrated 
that the use of an implant with a positioner in children was strongly associated with post-
implantation bacterial meningitis, resulting in the disuse of separate positioners. They also 
demonstrated that the joint presence of radiographic evidence of inner ear malformation 
and a cerebrospinal fluid leak was associated with an increased risk of postoperative 
meningitis, and the presence of a cerebrospinal fluid leak alone with an increased risk 
of perioperative meningitis (≤30 days after surgery).97 Despite the lower number of 
implantations and cases of meningitis in this series, this is the first study to demonstrate 
inner ear malformation alone as a risk factor for postoperative meningitis, although 
numerous case reports have noted the association between inner ear malformation and 
meningitis (without cochlear implantation).103 Loundon et al. also reported a significantly 
higher overall complication rate (including a misplaced electrode array, meningitis and 
Complication and device failure rates per five years are displayed in Fig. 2. A significant 
decrease in device failures was found over the years (chi-square (5 degrees of freedom) = 
105.50, p < 0.001), while the incidence of medical complications remained fairly constant 
(no significant diﬀerence between five-year periods).
Table 3  Device failures per device type.
Device type N Device failures
(%)
Mean follow-up 
(years)
3M/House 1 0 (0) 11.0
3M/Vienna 9 3 (33.3) 17.2
CII with HiFocus I electrode, no positioner 3 0 (0) 12.7
CII with HiFocus II electrode 8 0 (0) 13.5
CII with HiFocus II electrode, no positioner 7 0 (0) 11.1
Clarion 1.2 with Enhanced bipolar electrode 24 3 (12.5) 15.2
Clarion 1.2 with HiFocus I electrode 12 2 (16.7) 11.7
Combi40+ with Split electrode 1 0 (0) 2.1
Combi40+ with Standard electrode 3 3 (100) 1.1
ConcertoMi1000 with Flex28 electrode 1 0 (0) 3.9
ConcertoMi1000 with FlexSoft electrode 6 0 (0) 4.1
HiRes 90K Advantage with HiFocus 1j electrode 6 0 (0) 1.9
HiRes 90K Advantage with Midscala electrode 29 0 (0) 1.9
HiRes 90K with HiFocus 1j electrode 73 5 (6.8) 5.7
HiRes 90K with HiFocus Helix electrode 50 1 (2) 8.2
Laura 5 5 (100) 7.0
Nucleus 20+2L 16 1 (6.3) 19.3
Nucleus 24 75 2 (2.7) 15.5
Nucleus 24 with Contour Advance electrode 105 3 (2.9) 9.9
Nucleus 24 with Contour electrode 70 0 (0) 12.5
Nucleus 24 with Double Array electrode 5 0 (0) 8.5
Nucleus 24k 14 0 (0) 14.9
Nucleus 422 with Slim Straight electrode 69 0 (0) 2.2
Nucleus 512 with Contour Advance electrode 121 2 (1.7) 4.5
Nucleus Freedom with Contour Advance electrode 542 4 (0.7) 5.6
Nucleus Freedom with Hybrid-L24 electrode 5 0 (0) 7.8
Nucleus Freedom with Straight electrode 4 0 (0) 5.0
Nucleus Mini System 22 62 6 (9.7) 20.2
SonataTi100 with Flex28 electrode 3 0 (0) 3.7
SonataTi100 with FlexEAS electrode 11 0 (0) 6.7
SonataTi100 with Medium electrode 18 0 (0) 2.7
Synchrony with Medium electrode 4 0 (0) 1.1
Total 1362 40 (2.9) 7.9
Figure 2   Complication and device failure rates per five years.
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technological advancement. The failure rate of 2.9% in this series was somewhat lower 
than the 3.8% that was reported in a large multicenter study.111
4.5.  Conclusion
Risk factors identified in this study may give some leads to reduce the number of 
complications in the future. Unfortunately, no risk factors were identified for common 
complications such as seroma and chronic pain. To determine the eﬀect of factors such as 
prophylactic antibiotics, prospective trials are necessary (which is the third step in reducing 
complications). Because a higher rate of hematomas in patients with coagulation disorders 
and in implantation combined with subtotal petrosectomy was found, more attention to 
hemostasis is necessary in these patients (although most were grade I complications). 
Above all, this study stresses the need for pneumococcal vaccination, which may prevent 
general wound infections, but is especially important for patients with inner ear 
malformation, who have an increased risk of (postoperative) meningitis. Further 
precautions in these cases include a fibrous tissue seal around the electrode array at the 
cochleostomy site, and treatment of postoperative acute otitis media according to the 
protocol proposed by Rubin et al.112,113 Overall, cochlear implantation is a very successful 
and safe procedure with a limited number of serious complications, but the relative high 
number of minor complications still leaves room for improvement.
persistent CSF leak) in children with inner ear malformation, than found in the rest of their 
population.38
 In general surgery, risk factors associated with wound infections include co-morbidities 
(such as diabetes), advanced age, risk indices, patient frailty, longer surgeries and surgery 
complexity.104 In cochlear implantation, both a chronic health condition and a history of 
chronic ear disease have been suggested (but not statistically proven) as risk factors for 
postoperative infection.98,99 In this series, no association with immunodeficiency/-suppres-
sion or middle ear inflammation at the time of surgery was found. There is insuﬃcient 
evidence on the eﬀects of perioperative antibiotics on risk of infections after cochlear 
implantation.105 A relationship between the duration of antibiotic use and wound 
infections was neither found in this study, but this may be obscured by the fact that the 
majority of data was obtained retrospectively and no intention to treat analysis could be 
performed. Little is known about the bacterial flora in wound infections after cochlear 
implantation, or ear surgery in general. Although a negative association between 
Streptococcus pneumoniae vaccination and wound infections was found, a study on 
bacterial flora on explanted CIs did not show the presence of Streptococcus pneumoniae106, 
so the clinical relevance of this finding is unclear. 
 Other risk factors that were identified concerned hematoma: this was more common 
when a subtotal petrosectomy was performed (possibly due to the temporalis muscle 
flap) and in patients with a clotting disorder or anticoagulant use. Two previous studies 
found that coagulation disorders and incision type are predisposing factors for 
hematoma.107,108 Risk factors for seromas or postoperative chronic pain could not be 
identified. 
 Middle ear inflammation (including otitis media with eﬀusion) was not found to be a 
risk factor for postoperative wound infection or meningitis, although bleeding and 
swelling of the middle ear mucosa may make surgery more challenging. Insertion of a 
ventilation tube does not seem to be required in these cases.109
 Chorda tympani lesion/dysfunction was the most common complication. While few of 
these patients suﬀer from persistent taste disorder, thresholds on electrogustometry 
often remain elevated.110 Furthermore, the low number of patients with taste disorder 
after cutting of the nerve may be due to under-reporting, because patients are not always 
questioned on this subject postoperatively. 
 The incidence of medical complications was stable over the years. This does not 
mean that there is no learning curve in cochlear implantation (the implantations were 
done by surgeons with diﬀerent amounts of experience and functional results were not 
included), but the eﬀorts to reduce complications such as wound infections and seromas 
by reducing OR door swings and adjusting incision types and antibiotic regimens, seem 
to have borne little fruit. The number of device failures on the other hand, has decreased 
significantly over the years. This may partially be explained by the duration of follow-up, 
but since the mean time to device failure was 5.4 years, this is probably mainly due to 
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5.1.  Introduction
Cochlear implantation is a treatment for deafness and severe sensorineural hearing loss in 
pediatric and adult patients. Cochlear implants (CIs) bypass damaged or missing hair cells 
in the cochlea by directly stimulating auditory nerve fibers, allowing for speech perception 
in most users.
 Although very successful in most cases, the incidence of medical complications is 
somewhere between 6 and 63%37-39,81,82. These complications can be classified as minor or 
major complications. Minor complications are treated expectantly and/or with medication 
alone, while major complications require additional surgery and/or hospitalisation81. The 
incidence of major complications in cochlear implantation has been reported to be 
3.2–8.6%, with an overall incidence of infections of 0.4–5.2%37,39,81,96,98,114. General risk factors 
for wound infection are comorbidities (e.g. diabetes, chronic obstructive pulmonary 
disease and cardiovascular disease), increasing age and BMI, and complexity and/or 
duration of surgery104 For cochlear implantation specifically, a history of ear infections is a 
significant risk factor for postoperative infection98. When major infectious complications 
occur, the main treatment is surgical intervention and often device explantation, especially 
in cases with device exposure81,98. The management of these wound infections is complex, 
mainly because of the presence of biofilm, resulting in a reduced metabolic activity at the 
surgical site and a reduced eﬀect of many antimicrobial agents115
 Implantable gentamicin-impregnated collagen sponges such as Garacol®/Duracoll® 
have been popularized in recent years to prevent surgical site infections. We hereby report 
the results of the use of gentamicin sponges in salvage surgery for severe soft tissue 
infection after cochlear implantation in both pediatric and adult patients.
5.2.  Materials and methods
Four consecutive patients, who presented with severe wound infection after cochlear 
implantation (CIs of Cochlear®, Sydney, Australia and Advanced Bionics, Stäfa, Switzerland) 
in two clinics in Antwerp, Belgium and Nijmegen, the Netherlands, were included in this 
study. After full understanding of the aim and consent given for the treatment, three male 
patients and one female patient participated in this study. Age ranged from 2 to 80 years.
Surgical technique
All patients underwent salvage surgery in an attempt to resolve the infection and preserve 
the implant. Patients received antibiotic prophylaxis (cefazolin and metronidazole) 30 min 
before salvage surgery. The procedure consisted of a retro-auricular incision along the 
previous scar and removal of the infected skin. After thorough inspection and removal 
of granulation tissue, a new bed for the receiver and electrode was drilled. Garacol® 
Abstract
Cochlear implantation has an overall infection incidence of 0.4–5.2%. Major infectious 
complications often require device explantation. Gentamicin sponges may halt the 
infection through high local concentrations at the surgical site. This technique may reduce 
the need of device explantation and may lead to a possible cost reduction. Salvage 
surgery with gentamicin sponges was attempted in four patients with severe soft tissue 
infection after cochlear implantation. This was successful in two of four cases. Larger 
studies are needed to fully understand the eﬀectiveness.
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(the Netherlands) or Duracoll® (Belgium) gentamicin sponges (both of EUSA Pharma, 
Hemel Hempstead, UK) were placed in the newly drilled bed and, after the implant was 
placed in the bed, on top of the implant. Closure in two layers and a pressure dressing was 
applied. Postoperatively, patients were treated with antibiotics based on the available 
 microbiological cultures.
5.3.  Results
Of four patients included in our study, two patients had developed an early postoperative 
infection (<30 days) a week after cochlear implantation. Two patients had developed 
a delayed postoperative infection (>30 days) 3 months and 50 months after surgery. 
In two of four patients, the infection resolved completely. Follow-up ranged from 13 to 
27 months after salvage surgery (Table 1).
 The first patient had no risk factors for wound infection. Three months after 
implantation, the wound became dehiscent (Fig. 1A). Despite salvage surgery with 
gentamicin sponges 3 months later, the infection persisted and the device was removed. 
Our second patient had a history of frequent otitis. More than three years after cochlear 
implantation, there was extrusion of the device (Fig. 1B). After 2 months of conservative 
treatment, salvage surgery was performed. Twelve months after surgery, there was again 
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Figure 1  Wound dehiscence in patient 1 (A) and extrusion of the cochlear implant  
in patient 2 (B).
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tissue concentrations with lower risk of systemic toxicity. After implantation of a gentamicin 
collagen sponge (containing up to 130 mg gentamicin sulphate per sponge), within 24 h 
the concentration at the surgical site can reach concentrations up to 170 lg/mL. After 24 h, 
concentrations drop to an average of 10 lg/mL lasting up to 10 days, well above the minimum 
inhibitory concentration of 4–8 lg/mL for gentamicin-sensitive pathogens. Within 24 h, 
the systemic concentration drops below 2 lg/mL, well below the toxicity threshold116. 
The use of gentamicin absorbable sponges is considered safe with high, bactericidal 
concentrations at the surgical site without high systemic concentrations. The sponges are 
fully biocompatible and biodegradable and therefore do not have to be removed.
Comparison with other studies
Few reports have described the use of gentamicin sponges for wound infections in Cis39,117. 
Jeppesen et al.39 reported one case of successful treatment of soft tissue infection in CI 
with a gentamicin sponge (Gentacoll®) and intravenous cefuroxime. A recent study 
evaluated the eﬀectiveness and safety of gentamicin sponges in soft tissue infections in 
pediatric CIs. In all three patients, the infection resolved after salvage surgery using 
Collatamp® sponges with a follow-up of 12 months117. These infections consisted of serous 
fluid collections or hematoma without device exposure and therefore may be considered 
milder infections than our cases. Because one of our patients again developed device 
extrusion 12 months after salvage surgery, a 12- month follow-up period may be too short 
(follow-up in our series ranged from 13 to 27 months).
 There are multiple benefits in preserving implants. Aside from the emotional benefit 
for the patient, preserving the implant could possibly reduce costs. According to the 
Dutch Ministry of Health, Welfare and Sport, the standardized cost of the implantation of 
a single cochlear implant is estimated to be € 42.527. The gentamicin collagen sponges we 
used have an estimated price of € 170 per sponge measuring 10 x 10 cm, a small fraction 
of the price of a CI implantation we also expect it to be in other European countries. 
Therefore, besides that it might save the patient an extra procedure, salvage surgery with 
gentamicin sponges may lead to significant cost savings, even if only half of the implants 
are preserved.
5.5.  Conclusion
We demonstrated that salvage surgery with gentamicin sponges is a safe technique that 
might prevent device explantation in severe soft tissue infection. This was successful in 
two of four cases in our series, all in early postoperative infections without extensive 
device expo- sure. The use of gentamicin sponges results in high concentrations of 
gentamicin at the surgical site while minimizing the risk of systemic toxicity, without the 
need of removal of the sponge.
extrusion of the device and surgical removal was performed. The third patient had a 
history of progressive bilateral hearing loss due to otosclerosis. A week after cochlear 
implantation, the patient presented with fever and drainage of pus from the retro-auricular 
wound. Three days later, salvage surgery with gentamicin sponges was performed. After 
27 months of follow-up, no complications were seen. Our fourth patient had a history 
of insulin dependent diabetes and a probable hereditary progressive hearing loss since 
15 years. Seven days after implantation, the wound became dehiscent. The wound was 
treated with debridement and long-term antibiotics (tobramycin 3 days, intravenous 
ceftazidime 6 g/day for 6 weeks). This treatment was insuﬃcient and salvage surgery was 
performed 2 months later. Ceftazidime was continued for 2 weeks after the surgery. 
After a 13 month follow-up, no complications were seen.
5.4.  Discussion
There is no standardized treatment for surgical wound infection after cochlear implantation. 
Although mild infections may be treated with antibiotics alone, device explantation in 
severe infections is often considered the only treatment option to halt the infection81,98. 
The use of local gentamicin to treat the infection could be eﬀective in preserving the 
device, as shown in two of four patients in this study.
Effectiveness and safety
The time after surgery to develop soft tissue infection varied among our patients in this 
study. Two patients with an early postoperative infection showed good response to the 
salvage surgery with gentamicin sponges. In contrast, two patients with a delayed infection, 
3 and 5 months after surgery, did not have this positive outcome. It might be that the local 
application of gentamicin is more eﬀective in short onset infections after implantation, 
as shown in our results. This may be because long-term infections can be so advanced 
that treatment with local application is ineﬀective to control the process, or because these 
infections have a diﬀerent etiology. It is reported that wound infections with device exposure 
require device removal in 89% of the cases despite prolonged antibiotic treatment98, and 
this may also apply to salvage surgery with gentamicin sponges. To fully under- stand this, 
larger study groups are needed.
 Antonelli et al.106 recently studied pathogens in both infectious and non-infectious 
explanted CIs. In infectious CIs, Staphylococcus aureus was found significantly more often. 
Pseudomonas aeruginosa was also more common in the infected specimens but without 
significance. Our study also found these pathogens among the cultures of pre- and 
peroperative swabs, all sensitive to gentamicin treatment (Table 1).
 Aminoglycosides such as gentamicin are known to have a small therapeutic index. 
Local application of antibiotics, such as powder or sponges, can be used to achieve high 
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This relatively low-risk procedure may not only be beneficial for the patient but may also 
lead to a significant cost reduction. This technique seems very promising and larger future 
studies are needed to fully investigate the eﬀectiveness of this local application in CIs.
IV |  Surgical planning and evaluation 
of cochlear nerve implantation
6.  The transcochlear approach
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6.1.  Introduction
The first implanted electrical neural stimulator to restore hearing used a wire electrode 
implanted directly in the cochlear nerve 118. In following years, while Simmons reported 
promising results in patients implanted with wire electrodes in the modiolar nerve 119, 
House began his work on implanting wire electrodes in the scala tympani (ST), which 
eventually led to the development of modern cochlear implants 120. The main reasons to 
favor the ST over the modiolar arrays were the relatively easy surgical access to the ST, the 
straightforward tonotopic organization of the scala and the fear of damaging fibers of the 
cochlear nerve during the surgical procedure of implanting a relatively large electrode 
array into it. There are, however, several good reasons to revisit the concept of intraneural 
stimulation. 
 Directly stimulating the nerve fibers results in (a) lower energy requirements, (b) 
higher spatial selectivity, and (c) decreased chance of stimulating the facial nerve, a 
complication that is especially common in patients with otosclerosis 121. Since the cochlear 
nerve has a tonotopic organization in accordance to the cochlea, it is possible to represent 
the lower frequencies as the array can reach fibers originating from the cochlear apex 
(which is diﬃcult with intrascalar arrays).
 With the development of microelectrode arrays (which allow less traumatic insertion 
and more selective stimulation), several of these advantages were confirmed in animal 
studies. Implantation of various types of these arrays in the cochlear nerve of guinea pigs 
and cats led to up to 50-fold lower stimulation thresholds and a higher specificity of 
stimulation than with intrascalar stimulation 122, 123, 124, 125. Middlebrooks et al. additionally 
reported wider dynamic ranges and the successful stimulation of lower-frequency fibers 125. 
 Although results are promising, several issues have to be resolved for the development 
of a practical auditory prosthetic device that can equal the results of cochlear implants.
 We believe that the site most suitable for intraneural implantation is the distal end of 
the cochlear nerve. Just proximal to the lamina cribrosa, the cochlear nerve is separated 
from the facial and vestibular nerves (thereby reducing the risk of stimulation of these 
nerves) and nerve movement is limited by its fixation to the cochlea.
 Given otologic surgeons experience with posterior tympanotomy techniques in 
cochlear implantation, a modification of this procedure is a plausible surgical approach to 
reach the modiolar trunk. This approach is also a common technique used in animal 
studies on intraneural implantation where after the posterior tympanotomy, the round 
window (RW) is enlarged and the underlying modiolar wall is opened to expose the nerve. 
There are very few publications that discuss this approach in humans.
 Our aim was to investigate the suitability of a transcochlear surgical approach to the 
cochlear nerve while preserving intracochlear structures by using 3D models of human 
temporal bones (TBs). By implanting dummy probes into some of these TBs, we aimed to 
evaluate if our surgical planning was feasible.
Abstract
The objective of this study was to develop a transmastoid-posterior tympanotomy 
approach for the implantation of a penetrating auditory prosthesis in the most distal 
portion of the cochlear nerve. Animal studies suggest that penetrating cochlear nerve 
implants may overcome limitations of current cochlear implant systems. One step towards 
human implantation is the development of a suitable surgical approach. In computer 
rendered 3D models (based on micro-CT scans of 10 human temporal bones), we 
simulated trajectories through the most basal part of the cochlea that gave access to the 
most distal portion of the cochlear nerve with minimal damage to intracochlear structures. 
We determined their vectors with respect to the mid-modiolar axis and posterior round 
window edge and assessed if they intersected the chorda tympani nerve. The typical 
vector obtained with these 3D models ran in an anterosuperior direction, through the 
inferior part of the facial recess and anterior round window edge. In 7 out of 10 temporal 
bones, this trajectory intersected the chorda tympani nerve. Based on the vectors, dummy 
probes were implanted in 3 out of 10 temporal bones and the need for chorda tympani 
removal was confirmed in accordance with the 3D models. Postoperative micro-CT scans 
revealed that all probes were successfully implanted in the cochlear nerve while the 
osseous spiral lamina and basilar membrane were preserved. The vector for drilling and 
implantation found in this study can be used as a guideline for real-life surgery and 
therefore is another step towards the clinical implementation of cochlear nerve implants.
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d) The vector had to run medial from the OSL/basilar membrane (at the scala tympani 
side) to prevent opening the scala media;
e) The vector had to run through separate openings in the lateral and medial cochlear 
wall to preserve the scalar floor;
f) The vector had to run through the most distal portion of the nerve as possible, where 
it is fixed to the base of the cochlea and separated from the facial nerve by the falciform 
crest. 
The optimal position of the vector was acquired by manual translation along and rotation 
around a point on the MMA (Fig. 1a). For instance, the vector was positioned as far to the 
basal end of the ST by rotating it around the MMA until it just fitted between the OSL and 
the scalar floor, and the most distal portion of the nerve was reached by maximizing the 
angle between the vector and the MMA. When this position was reached, we characterized 
this vector by measuring the rotational and translational components. The rotation of the 
vector around the MMA was measured on a reconstructed CT slice perpendicular to the 
MMA by using the posterior RW edge as the 0º starting point (Fig. 1b). We measured the 
6.2.  Materials and methods
The CT device of an Inveon™ small-animal PET/CT system (Siemens Healthcare, Erlangen, 
Germany) was used to acquire micro-CT scans of ten formalin-fixed human TBs. As the 
field of view of the acquisition protocol for the preoperative evaluation was 41 x 61 mm, 
the TBs were cut to a cylindrical shape to fit this volume. Care was taken to ensure that all 
anatomical landmarks that could limit the surgical approach (such as the sigmoid sinus) 
were included in the specimen. The protocol consisted of the following settings: X-ray 
source voltage: 80 kV; X-ray source current: 500 mA; exposure time: 1000 ms; rotation: 202º; 
and steps: 202. This resulted in reconstructed image files with a voxel size of 0.04 mm. For 
the visualization of soft tissues and the implanted probes, we used an acquisition protocol 
with a higher magnification (field of view of 32 x 21 mm), more rotational steps (360º, 720 
steps) and a voxel size of 0.01 mm.
We applied a similar method as used by Meshik et al. (to analyze cochlear implant insertion 
vectors) 126 to create 3D models of the TBs. Using AMIRA imaging software (Visage Imaging, 
Carlsbad, USA), we rendered two surface models of each TB: one of the high resolution 
micro-CT scan of the basal turn, and one of the normal resolution scan of the complete 
bony labyrinth and facial nerve. These two models were fused to create one model that 
contained all the structures that were relevant for our surgical planning (osseous spiral 
lamina [OSL], cochlear nerve, etc.). Using a multiplanar reconstruction tool, we selected 
the mid-modiolar axis (MMA) in these models. We then created a cylindrical shaped 
object with a diameter of 0.8 mm and a length of 20.0 mm to act as an implantation 
vector. We chose this diameter because the height of the ST in the first half of the basal 
turn decreases from approximately 1.25 mm to 1.03 mm 127,128, the vector would probably 
not run fully perpendicular to the OSL and we aimed to preserve the veins located on 
the floor of the scala (because we believe that destruction of these veins, which drain 
the spiral ganglion and external walls of the scala tympani and media, might negatively 
aﬀect these structures and lead to entry of blood into the scala tympani) 129, 130. Next, 
we attempted to fit this implant vector into the surface model based on six formulated 
criterions applied in the following order (the first being the most important):
a) The vector had to run between the facial nerve and the annulus fibrosis tympanicus 
(consistent with the posterior tympanotomy approach); 
b) The vector had to run through the MMA at the level of the cochlear nerve, representing 
the center of the nerve and location of the low-frequency fibers;
c) The vector had to run as far to the basal end of the ST as possible, sacrificing only the 
highest frequency spiral ganglion cells (which have little clinical relevance because 
they fall outside the frequency range of speech) and giving the highest chance of 
survival for the chorda tympani nerve (CTN); 
Figure 1  Positioning and characterization of the vector in the 3D models. (a) Directions 
of translation (A) and rotation (B and C) of the vector in TB 10; V: vector. (b) Measurement 
of the angle between the vector and the posterior RW edge in two intersecting orthogonal 
planes in TB 4. (c) Measurement of the angle between the vector and the MMA (88.4º) and 
the distance between the vector and the distal nerve end (0.98 mm) in TB 4.
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probes into the cochlear nerve. After insertion, the proximal part of the probe was glued 
using Loctite 495 cyanoacrylate adhesive (Henkel, Düsseldorf, Germany) to the anterior 
margin of the facial nerve for fixation. The implanted TBs were rescanned with the 
high-resolution protocol to assess probe placement. Using OsiriX 64-bit Imaging Software 
(Version 3.7) we selected the MMA in a multiplanar reconstruction and used the plane 
perpendicular to the MMA to measure the angle between the posterior RW edge and the 
line running parallel to the probe and through the MMA, the distance between the probe 
and the MMA and the diameter of the nerve in the same direction. In the plane of the 
probe, parallel to the MMA, we judged the OSL, basilar membrane and insertion depth of 
the probe and we also measured the angle between the MMA and the probe. In the plane 
perpendicular to the probe and through the MMA, we measured the distance between 
the probe and the distal nerve end (Fig. 2).
6.3.  Results
After creating the 3D models, we succeeded in positioning the vectors in every case 
without violating the predetermined conditions. Table 1 shows the characteristics for 
each vector. The most important factor for positioning the vectors in the surface models 
was the distance between the OSL and the ST floor. As the OSL curves around the RW 
(when seen through the facial recess, the orientation changes from vertical at the superior 
RW edge to horizontal at the anterior edge 131), the space between the OSL and the scalar 
floor increases in the hook region before gradually decreasing further along the cochlear 
spiral. Positioning the 0.8 mm diameter vector as close to the basal end of the cochlea as 
possible resulted in a mean angle with the posterior RW edge of 12.8º. This coincided with 
the vector running through the anteromedial portion of the RW and, in 8 out of 10 cases, 
just through the adjacent cochlear wall. Therefore, the course of the vector was steeper 
than the trajectory used in cochlear implantation (i.e. more postero-inferior to antero- 
superior), which meant that in all cases the vector ran through the inferior portion of the 
facial recess, close to, or even at the bifurcation of the CTN. The vector intersected the CTN 
in 7 out of 10 models because either the distance between the two nerves was too small 
to accommodate the vector or the vector ran oblique with respect to the plane of the 
facial recess. The vector did not cross the posterior wall of the external auditory canal in 
any of the models. Inside the internal auditory canal, all vectors ran more or less parallel to 
the falciform crest and therefore inferior to the facial and the superior vestibular nerves 
and distal from the point where the inferior vestibular nerve joins the cochlear nerve. 
 Two probes with one shank and one probe with four shanks were used for 
implantation in three TBs. Irrespective of the results of the micro-CT analysis, we initially 
attempted to preserve the CTN in all three TBs. This posed no problem for the opening 
and enlarging of the RW but prohibited drilling of the planned trajectory in TB1 and TB2, 
distance between the distal nerve end and the vector on the MMA in a slice in the plane 
of the axis. The angle between the center of the vector and the MMA could be measured 
directly (Fig. 1c). We also measured the length of the trajectory from the posterior edge of 
the facial nerve to the bony wall of the internal auditory canal that the vector reached 
after it traversed the cochlear nerve. Furthermore, the distance between the CTN and the 
facial nerve in this plane was measured and we assessed if the vector ran through the 
CTN. All measurements were repeated three times and the mean values were calculated. 
 A complete mastoidectomy and posterior tympanotomy was performed on three of 
the ten TBs. If necessary, the posterior tympanotomy was extended by removing the CTN. 
The subiculum was drilled away for a full view of the RW, the membrane was removed 
and, if necessary, the RW was enlarged. Based on the trajectory of the vector, an opening 
was drilled in the medial wall until the nerve was reached. We used two types of thin-film 
micro-electrode arrays developed for neural tissue stimulation in animals (NeuroNexus 
Technologies, Ann Arbor, USA). These ‘C-Style’ probes (typical thickness 15 µm, shank 
width 150 µm and total length 14 mm) consist of 16 electrode sites divided over one or 
four shanks attached to an integrated silicon cable. We used teflon coated Dumont #5 
forceps (Fine Science Tools, Heidelberg, Germany) and an otologic pick to insert these 
Figure 2   Multiplanar reconstruction used for postoperative measurements.
Right: mid-modiolar reconstruction, perpendicular to probe. Solid line represents MMA, dotted crosshairs on 
probe represent other reconstructed planes. Upper left: plane perpendicular to the MMA (solid cross), arrow 
points at posterior RW edge. Lower left: paramodiolar reconstruction in the plane of the probe, asterisk: probe 
implanted through the enlarged RW.
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distance between the probe and the distal nerve end in both TB2 and TB3 (Table 1). This 
again, meant that the tip of the probe was proximal to the falciform crest. Also, all three 
probes crossed inferiorly from the MMA (especially in TB3 where the probe was inserted 
in the inferior edge of the nerve [distance between probe and MMA was almost half the 
diameter of the nerve]) (Fig. 4a and b). In TB1 and TB3, this was mainly caused by the probe 
being directed too inferiorly (the angle between the posterior RW edge and the line 
running parallel to the probe and through the MMA was too small, with the hole in the 
modiolar wall at the correct location) and in TB2 the hole in the modiolar wall was too far 
away from the basal end (the aforementioned angle was too wide, yet the probe still 
crossed the MMA inferiorly). Furthermore, we found that by drilling the modiolar wall in 
TB3, the apertures of the inferior cochlear vein and cochlear aqueduct were compromised. 
In the other two TBs, these structures remained intact.
thus confirming the findings in the micro-CT analysis. As drilling the modiolar wall would 
result in a course just inferior of the internal auditory canal, we decided to extend the 
posterior tympanotomy by removing the CTN. Although the CTN made it diﬃcult to drill 
the modiolar wall under the right angle and reduced our view, in TB3 it was possible to 
access the cochlear nerve while preserving the CTN. Drilling the modiolar wall destroyed 
some of the nerve fibers running from the organ of Corti to the cochlear nerve. Due to the 
size of the drill hole, some nervous tissue could be seen, yet there was no view of the 
nerve as a whole. This made it impossible to determine the axis of the nerve with precision 
and we therefore had to rely on the vector estimates. All probes were inserted until 
resistance was felt (Fig. 3).
 The post-operative CT scans revealed that the probes were successfully implanted in 
the cochlear nerve and the OSL and basilar membrane were intact in all three cochleae, 
however the probe fully traversed the nerve in only TB1 (see Fig. 4a and Video [http://links.
lww.com/MAO/A111], which demonstrates the implanted probe in a volume rendering 
of TB1). In TB2 the probe was incompletely inserted (1.9 mm of the 2.9 mm nerve diameter 
in this direction, although the probe was 6.0 mm in length) and in TB3 the probe was 
completely inserted but too far in the direction of the nerve rather than perpendicular to 
it (Fig. 4b). This was expressed by the angle between the probe and the MMA, which was 
more than 10º smaller than we planned with the vector and also resulted in a larger 
Figure 3  View through the extended facial recess on the probe implanted through the 
enlarged RW; the probe rests on the facial nerve (FN) and enters a drill hole in the modiolus 
(asterisk), just below the basilar membrane, at the most basal part of the cochlea; the 
arrow indicates the course of the basal turn; S: stapes.
Figure 4  Distance between the probe and the MMA in TBs 1 (A) and 3 (B). 
Crosshairs represent the position of the MMA, CN: cochlear nerve, FC: falciform crest. Note the probe not fully 
traversing the nerve in TB 3 due to the non-perpendicular insertion.
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6.4.  Discussion
Using 3D surface models based on micro-CT scans of 10 human TBs, we selected the 
optimal vector for implantation of a cochlear nerve implant via the mastoidectomy 
posterior tympanotomy approach. Our goal was to find a route through the lateral and 
medial wall of the ST without compromising the OSL and basilar membrane. We were 
able to create this vector in every model although it coursed through the CTN in seven 
cases. Based on these vectors, we implanted a dummy probe in three of the TBs and by 
using micro-CT we were able to assess the position of the micro-electrode array. Although 
it was diﬃcult to attain the planned vector position, all probes were successfully implanted 
into the nerve.   
There are few reports on transcochlear approaches for cochlear nerve implantation in 
humans. Simmons’ report on implanting a four-electrode wire array in two human 
subjects described how he drilled a hole through the promontory into the scala vestibuli 
to reach the modiolus and, in doing so, destroyed the nerve fibers in the most basal 
portion of the first turn 132. Badi et al. used the extended facial recess approach to access 
the modiolar nerve in two human TBs. Although this approach sacrifices the CTN, they 
reported that access to the nerve was 2 x 3 millimeters and that the procedure was not 
significantly more diﬃcult than the posterior tympanotomy approach used in cochlear 
implantation. There is no mention of the basilar membrane or OSL, but based on the size 
of the nerve exposure, these were probably removed 124. 
 The transcochlear technique used by Middlebrooks et al. for the implantation in cats 
consisted of making a hole in the OSL with a 30-gauge needle (0.31 mm outer diameter) 125. 
Therefore, the electrode array is inserted in the modiolar trunk of the nerve, while our 
approach on the other hand, gave access to the complete cochlear nerve, proximal to the 
lamina cribrosa. 
Attempts were made to develop an approach to the modiolar nerve that does not 
necessitate the opening of the cochlea, but according to Paasche et al., this was not 
feasible with current technology 133.
There are several studies on the size of the (extended) facial recess, RW and their 
topographical relationship 134-137. Several authors conclude there is no diﬀerence in facial 
recess width between children and adults 134,135, which means that our results might be 
applicable to children as well. 
One limitation of our study was that all actions in the 3D models were manually performed, 
which implies certain inaccuracy. To minimize the variation in MMA orientation (which 
aﬀects placement of the vector and subsequent measurements), we selected the MMA Ta
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implantation and stimulation in both animal and human subjects, ranged from little 
damage to nerve fibers 122, 147 to extensive loss of spiral ganglion cells and axons, probably 
due to diﬃcult electrode insertion and chronic implant movement 148. A pneumatic 
insertion device has been developed to minimize tissue damage 149, but more research on 
this subject is essential.  
 Another drawback is that while intraneural implantation gives access to the entire 
cochlear frequency spectrum, the tonotopic organization of the cochlear nerve is much 
more complex than that within the cochlea. Therefore, postoperative mapping will be 
more challenging than with conventional cochlear implants (probably similar as in 
auditory brainstem implantation).
Unlike the guinea pig’s cochlea, which protrudes in an air-filled bulla, the human cochlea 
is embedded in bone, which makes it hard to choose the right trajectory in the modiolar 
wall to reach the desired part of the cochlear nerve. As the optimal vector runs through- 
or slightly superior- from where the CTN branches from the facial nerve and through the 
anterior part of the RW, these landmarks should be used to guide drilling of the modiolar 
wall. With regard to the anteroposterior orientation, we recommend starting the trajectory 
as close as possible to the anterolateral surface of the facial nerve (in the facial recess) and 
pass as close as possible to the medial side of the bony spiral lamina to insert the probe 
almost perpendicular to the cochlear nerve and close to the fundus of the cochlea at the 
level where the nerve is still separated from the facial and vestibular nerves.  
We also recommend removing the CTN if the round window approach is used for 
intraneural implantation. Based on our CT findings, in 3 out of 10 TBs it was possible to drill 
a trajectory that was 0.8 mm in diameter without sacrificing the CTN. An important aspect 
to consider when drilling the modiolar wall is the risk of the drill bur becoming lodged in 
the inferior portion of the facial recess as the bur shaft may be wider than the head of the 
bur. This may lead to heat damage to the facial nerve. Also, removing the CTN gives a 
better view on the exposed nerve and makes it easier to enlarge the drill hole in the 
modiolar wall in an anterior direction to expose a larger part of the nerve for implantation 
of a larger electrode array, if desired. This is supported by the results in TB3 where the CTN 
was preserved but the implantation was more diﬃcult, the cochlear aqueduct and ICV 
were damaged and the results were less preferable than in the other cases. 
Sectioning the CTN has three disadvantages: it can lead to loss or alteration of taste, 
decrease in tongue sensation or, less common, xerostomia. Although these symptoms 
occur in 40-60% of patients, for 94-96% of these patients the symptoms are no longer 
present two years post-surgery. Electrogustometry thresholds on the other hand, often 
remain elevated 83,84. A possible solution to spare both the CTN and the OSL would be to 
pass inferiorly from the CTN. This however, would require drilling a large cochleostomy 
based on the apical 1.5 turns of the cochlea. Skinner et al. first applied this method because 
this is the point where the cochlear spiral is coiled the tightest 67. Nonetheless, as the MMA 
was separately selected in the pre-operative and post-operative scans, some of the 
diﬀerences between the position of the vector and the probe might be accounted for by 
a slight variation in orientation of the MMA. Another limitation may be that we based our 
vector criteria on minimizing damage to labyrinthine structures. In cases where there is a 
complete loss of labyrinth function, it may be unnecessary to sacrifice the CTN in favor of 
limiting damage to the labyrinth. Another requirement we set for our vector was that it 
ran through the most distal portion of the nerve. As a consequence, the vectors ran 
almost perpendicular to the nerve, yet it is unknown whether this is the best direction for 
electrical stimulation.
The round window approach itself also has some drawbacks. As the trajectory passes 
through the modiolar wall of the ST, the spiral ganglion cells in this region are destroyed 
(a line that runs from the anterior RW edge to the axis of the cochlea, crosses spiral 
ganglion cells that represent frequencies of about 17 kHz 138. The loss of these fibers has 
little clinical relevance as long as the size of the opening in the modiolar wall is limited. 
Our results demonstrated that drilling the modiolar wall also endangers the cochlear 
aqueduct and inferior cochlear vein (ICV). While the obliteration of the cochlear aqueduct 
probably has no eﬀect on the inner ear 139, damaging the ICV may lead to bleeding into 
the basal turn. Moreover, extensive or proximal occlusion of this vein in the guinea pig is 
known to lead to reductions in blood flow, changes in cell structure and cochlear function 
(in contrast to more distal occlusion, which has less severe eﬀects) 140, 141, 142. However, the 
collateral drainage system in man is probably more eﬀective, via the vein of the cochlear 
aqueduct (which may be absent or very small in the guinea pig) 143. Contrary to the 
principles of soft surgery in cochlear implantation, the cochlea is opened for a longer 
period, drilling of the modiolar wall releases bone dust inside the cochlea and suctioning 
of perilymph might be necessary for visualization. These factors will most likely lead to loss 
of residual labyrinthine function 144,145,146.
 Also, a posteriorly angled external auditory canal might possibly impede visualization 
of the RW membrane. However, we did not encounter this problem in our models or in 
the temporal bones, probably because of the inferior to superior direction of our vector 
(in contrast to a more posterior to anterior direction in conventional cochlear implantation) 
and removal of the CTN.
One of the dangers of intraneural implantation is causing damage to the fibers of the 
cochlear nerve. Although most probes slid quite easily between the nerve fibers in our 
study, we noticed that is was harder to insert probes with broader shanks. Packing of the 
RW to stop perilymph leakage after implantation should also be done with great care in 
order to prevent electrode movement and nerve damage. Histological results of chronic 
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instead of enlarging the round window and as such, sacrificing lower frequency spiral 
ganglion cells and inserting the probe less perpendicular into the nerve (as the descending 
portion of the facial nerve runs somewhat anteriorly).
Intraneural implantation could be an alternative for patients with a severely ossified or an 
obliterated cochlea. Based on current treatment, these patients are required to undergo 
either a drill-out of the ST or auditory brainstem implantation. Both these procedures lead 
to less favorable results than ‘regular’ cochlear implantation 150,151. Alternatively, intraneural 
stimulation may be used as a supplement to current cochlear implant systems; the intra- 
neural implant could stimulate low frequency fibers while the cochlear implant stimulates 
the remaining frequencies. 
6.5.  Conclusion
Based on 3D models of 10 TBs and applied surgically in 3 TBs, we attempted to create a 
transcochlear surgical approach to implant a cochlear nerve prosthesis that preserves 
both the OSL and basilar membrane and sacrifices only the most basal spiral ganglion 
cells. Although our conclusions are based on a relatively small series of TBs, we believe that 
the optimal trajectory runs from the point where the CTN branches from the facial nerve, 
through the anterior RW edge and modiolar wall, to the most distal portion of the cochlear 
nerve. Both our CT and clinical findings suggest that the CTN should be sacrificed to 
perform this procedure.
IV |  Surgical planning and evaluation 
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7.  The extended infralabyrinthine approach
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7.1.  Introduction
Parallel to the ongoing success of cochlear implantation, several studies have been 
published in the last decade on the subject of intraneural cochlear nerve stimulation 152,153. 
There are several reasons to consider a cochlear nerve implant as an alternative auditory 
prosthesis. One reason is that the progress in performance with cochlear implants (CIs) 
seems to have slowed down in recent years. Since their introduction, CIs have exceeded 
all expectations and new applications such as bilateral implantation and electro-acoustic 
stimulation have produced significant improvements, but representation of temporal fine 
structure (which is necessary for speech perception in noise and music appreciation) is still 
limited 28,154. Optimizing electrode placement and current steering seems promising, but 
has led to little improvement in speech perception so far 70,72,155,156. Although it is diﬃcult to 
evaluate such eﬀects due to the heterogeneity of results in CI recipients, some of the 
limits inherent to intrascalar stimulation may not be overcome. Intraneural implants may 
oﬀer the prospect of higher spatial resolution, lower stimulation thresholds and stimulation 
of low-frequency fibers, thus overcoming these limits 148. Another reason is the possible 
application of an intraneural implant in patients with compromised cochleae. Both 
cochlear implantation after cochlear drill-out in patients with non-patent cochleae and 
auditory brainstem implantation, lead to speech perception outcomes that are less 
favorable than with regular cochlear implantation 150,151. A third possible application might 
be to use it as a supplement to current CI systems: the low frequencies that are diﬃcult 
to stimulate with CIs, can be stimulated with penetrating electrodes, while the other 
frequencies are stimulated with the CI. 
 While animal studies with cochlear nerve implants have shown some promising 
results, implementation in humans is still far away. One of the steps towards tests in human 
subjects is the development of a surgical approach for intraneural implantation. 
In animal studies, and also in three human subjects in the 1960’s and 70’s, a transcochlear 
approach was used to implant electrodes in the modiolar portion of the nerve 119,124,132. We 
have studied a transcochlear approach to the most distal portion of the nerve ourselves, 
but this approach required prolonged opening and drilling on the inside of the cochlea 
(most likely leading to loss of residual labyrinthine function), gave limited access to the 
nerve and required sacrificing the chorda tympani nerve, at least when the vestibulum 
and osseous spiral lamina were to be spared 157. 
 The infralabyrinthine approach was introduced by Vernick to gain extracranial access 
to at least the proximal half of the internal auditory canal (IAC) while preserving the bony 
labyrinth, which allowed selective sectioning of the vestibular nerves in patients with 
severe vertigo 158. We explored the possibility to gain access to the antero-inferior quadrant 
and most distal portion of the cochlear nerve (where the cochlear nerve is completely 
separated from the facial and vestibular nerves and least subject to movement of the 
Abstract
An electrode array implanted directly into the cochlear nerve might overcome limitations 
imposed by current cochlear implant systems. To demonstrate the feasibility of extra- 
cochlear cochlear nerve implantation, we used an extended infralabyrinthine approach 
(EILA) to allow access to the nerve. After obtaining pre-operative micro-CT scans for 
morphometric evaluation, the EILA was attempted in ten human formalin-fixed temporal 
bones. If access to the nerve was gained, a dummy probe was implanted and a post- 
operative micro-CT scan was made for evaluation. This was successful in 8 out of 10 
temporal bones. In the remaining 2, a high jugular bulb blocked access to the nerve. 
Assessment of the implantations revealed that all probes were implanted into the cochlear 
nerve, 1 traversed into the facial nerve and in 2 cases, the basal turn was damaged. Success 
of the approach was related to the distance between the jugular bulb and the posterior 
semicircular canal. The EILA is a complex procedure, which allows transmastoid, extra- 
cochlear access to the cochlear nerve for implantation of an auditory prosthesis. Patients 
with high jugular bulb should be excluded by pre-operative CT analysis.
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In a multiplanar reconstruction we selected the plane of the posterior semicircular canal 
(PSC; Fig. 2A). Because the PSC is not completely ‘flat’, we used the plane with the widest 
canal diameter. In this plane, we measured the distance between the PSC and the jugular 
bulb (JB). When the JB was located medially from this plane, we measured the distance to 
the inferior margin of the skull base. By scrolling laterally to the level of the facial nerve 
(FN), we set one line of the crosshairs over the axis of the mastoid segment of the FN so 
that we were able to move the plane perpendicular to this axis to diﬀerent levels along the 
FN to conduct our measurements. Level I was at the point where the FN crossed the 
midpoint of PSC; in this plane we measured the distance between the FN and the PSC (in 
most cases this was the ampulla of the PSC). Level II was just inferior to the PSC (Fig. 2B); 
here we measured the distance between the FN and the posterior fossa dura (PFD)/
endolymphatic sac and the distance between the FN and the sigmoid sinus (SS; in cases 
with a less protruding sinus, this was the point of transition between the sinus and the 
PFD). Level III was at the most superior aspect of the JB, were we measured the distance 
between the FN and the top of the JB. Next, we selected the mid-modiolar axis (MMA) 
based on the apical 1.5 turns of the cochlea. In a mid-modiolar reconstruction, we 
measured the distance from the most distal part of the IAC to the proximal edge of the 
falciform crest (Fig. 2C) and to the distal edge of the singular foramen (transmitting the 
posterior ampullar nerve) along this axis. 
 After acquiring the micro-CT images, a complete mastoidectomy and posterior 
tympanotomy was performed on each TB. Care was taken to completely skeletonize the 
brain) with a modified version of this approach, by partially removing the mastoid tip and 
drilling towards the IAC from an inferior to superior direction (Fig. 1). The goal of this study 
was to investigate the feasibility of implanting a penetrating auditory prosthesis in the 
cochlear nerve using this extended infralabyrinthine approach (EILA) in the human 
cadaver temporal bone (TB) specimens.   
7.2.  Material and methods
Ten randomly selected, formalin-fixed human TBs (6 left and 4 right) were cut to a 
cylindrical shape of 4 x 6 cm to fit the maximum field of view of the micro-CT device of 
an Inveon™ small-animal PET/CT system (Siemens Healthcare, Erlangen, Germany), while 
preserving all anatomical landmarks that can limit the surgical approach. The following 
acquisition protocol was used: X-ray source: 80 kV, 500 mA; exposition time: 1000 ms; 
rotation: 202º, 202 steps; FOV: 60.8 x 40.6 mm. We exported the reconstructed image files 
with a voxel size of 0.04 mm to DICOM format with Inveon Research Workplace and 
conducted distance measurements using OsiriX MD (Pixmeo, Geneva, Switzerland). 
Figure 1  Exploratory attempts to access the cochlear nerve (CN) using the extended 
infralabyrinthine approach in a human temporal bone (left side). A: Transmastoid surgical 
access to the CN in the opened internal auditory canal, just proximal to the cochlea. 
The opened and enlarged round window (RW) provides a view on the scala tympani and 
osseous spiral lamina; dotted line indicates the original RW position. Facial nerve removed 
for photograph. B: View from the middle fossa on cochlea and internal auditory canal in 
the same temporal bone. Horizontal segment of FN, geniculate ganglion and greater 
petrosal nerve (GPN) removed, and cochlea and internal auditory canal opened for 
illustrative purposes. Arrowheads indicate the transmatoid access to the CN, dashed line 
indicates original course of the FN. FC: falciform crest; SVN and IVN: superior and inferior 
vestibular nerves.
Figure 2  A: Plane of the posterior semicircular canal (PSC) with a projection of the course 
of the facial nerve (FN; curved dotted lines) and its axis (vertical dotted line) in TB 9. The 
distance PSC to jugular bulb (JB) was measured in this plane (double arrow). Horizontal 
dotted lines I to III designate the levels of the planes used for the other measurements. 
IAC: internal auditory canal; SS: sigmoid sinus. B: Example of the measurements at level II 
in TB 5. Arrows indicate the shortest distances FN (outlined in black) to posterior fossa dura 
(PFD) and FN to SS. ME: middle ear; C: cochlea; *: inferior edge of PSC. C: Example of the 
measurement of the length of the falciform crest (FC), from its proximal edge to the distal 
nerve end along the mid-modiolar axis (MMA), in a mid-modiolar reconstruction of TB 9.
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After implantation, another micro-CT scan was obtained from each TB to assess the 
position of the probe. In order to maximize the soft tissue contrast and visualize the probe, 
we used the following acquisition protocol: X-ray source: 60 kV, 500 mA; exposition time: 
9000 ms; rotation: 360º, 720 steps; FOV: 31.8 x 21.2 mm. The reconstructed voxel size of 
these images was 0.01 mm.
 In a multiplanar reconstruction we evaluated the implantation by obtaining the 
following parameters: in the plane perpendicular to the probe and through the MMA, we 
measured the distance between the probe and the MMA, the nerve diameter in this 
direction, the distance between the probe and the distal nerve end along the MMA and 
determined whether the probe ran antero-inferior or posterosuperior to the MMA. In the 
plane of the probe and parallel to the MMA, we measured the angle with the MMA, the 
insertion depth and the nerve diameter in this direction. To ascertain that the narrow tip 
of the probe was completely visualized, we checked the length of the shank in the 
micro-CT scan with the manufacturer’s specifications. We also evaluated if one of the 
following structures was damaged: PSC, posterior ampullar nerve, basal turn, ICV and CA. 
Using SPSS 16.0 (SPSS Inc., Chicago, USA), we tested for relationships between the anatomic 
measurements in the pre-operative micro-CT scans, success of the approach, the probe 
characteristics, and results of the implantation.  
SS, the PFD and endolymphatic sac and the mastoid segment of the FN. Through the 
facial recess, bone was removed anterior and medial to the FN. Next, the PSC was 
blue-lined in the direction of the ampulla and the retrofacial cells were removed, exposing 
the JB. Following the retrofacial tract, drilling was continued just proximal from the round 
window, towards the IAC (Fig. 3). By drilling in this direction, both the cochlear aqueduct 
(CA) and the inferior cochlear vein (ICV) were encountered and sacrificed. In order to 
visualize the most distal part of the IAC it was necessary to extend the mastoidectomy 
inferiorly by drilling away part of the mastoid tip and lowering the edge of the 
mastoidectomy to the level of the SS. However, the bone covering the SS was preserved 
in all TBs. Bone was removed from the antero-inferior portion of the IAC and the exposed 
dura was slit along the axis of the canal, uncovering the cochlear nerve underneath. 
For the implantation we used several types of thin film microelectrode arrays, developed 
for stimulation of neural tissues in animals (NeuroNexus Technologies, Ann Arbor, USA; 
Fig. 4). Using Teflon coated Dumont #5 forceps (Fine Science Tools, Heidelberg, Germany), 
we inserted these probes into the most distal portion of the cochlear nerve. By aiming 
slightly laterally, we attempted to let the tip of the probe rest on the falciform crest after 
penetrating the cochlear nerve, preventing insertion into the FN. After the insertion, the 
proximal part of the probe was glued to the bone covering the PFD using Loctite 495 
cyanoacrylate adhesive (Henkel, Düsseldorf, Germany) to prevent displacement.
Figure 3  A: A single-shank probe implanted through the extended infralayrinthine 
approach in TB 4. Inferior view on the TB after partial removal of the mastoid tip (MT). 
Dashed arrow follows the blue-lined posterior semicircular canal (PSC) and points towards 
the internal auditory canal. JB: jugular bulb; FN: facial nerve; SS: sigmoid sinus. B: Volume 
rendering of a 4-shank probe (P) implanted in the cochlear nerve (CN) in TB 9. Some debris 
from the accidental fenestration of the medial side of the cochlea is visible through the 
round window (RW). Cross-section through the basal turn (C) permits a view on the osseous 
spiral lamina. S: stapes.
Figure 4  The various probe designs used in this study. These probes consist of 16 
electrode sites divided over one or four shanks attached to an integrated silicon cable, 
with a typical thickness of 15 µm, shank width of 150 µm and total length of 14 mm (‘C’ 
style probes). The probes consist of the actual probe (the tip), a silastic bead coated on a 
tab for handling, and a more flexible integrated ribbon cable.
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In all the TBs where the EILA was successful, we found that the ICV and CA were indeed 
both destroyed (Fig. 6). Furthermore, we detected that we accidentally created a 
fenestration in the basal turn of the cochlea in 2 TBs (Fig. 3B). In none of the TBs, the PSC 
or the posterior ampullar nerve was damaged. 
Specific measurements on the implanted probes are displayed in Table 1.
7.3.  Results
The results from the pre-operative distance measurements and related descriptive 
statistics are displayed in table 1. We found the largest variation in the distance PSC to JB, 
which had a coeﬃcient of variation (CV) of 0.46, followed by the distance FN to JB with a 
CV of 0.19. In the plane parallel to the PSC (Fig. 2A), the JB was located anterior to the FN in 
all cases. In 3 TBs, the JB was located medially to this plane and thus the distance from the 
PSC to the inferior edge of the skull base was measured instead of to the JB. We did not 
find significantly diﬀerent distances between right and left TBs. 
Using the EILA, we succeeded in opening the IAC in 8 out of 10 TBs, while no further 
problems were encountered during the procedure. In TB 3 and TB 10, the approach was 
blocked because the distance between the PSC and the JB was too small to allow drilling 
towards the IAC. We did not attempt to depress the JB in these cases and sectioning the 
endolyphatic duct (which was suggested by Vernick in case of a high JB) was not useful 
because our approach was inferior to the duct. The SS did not prove to be an obstacle for 
the approach in any of the TBs.
 After opening the IAC in TB 1, we found that the cochlear nerve had accidentally been 
removed, probably during removal of the TB from the cadaver. In the remaining 7 TBs, 
opening the IAC allowed wide exposure of the nerves and the probes could be inserted 
at the preferred location and angle (Fig. 3). Eventually, we implanted 3 wide and 2 narrow 
4-shank probes (total width of 0.87 and 0.55 mm, respectively) and 2 single-shank probes 
of diﬀerent width and length. We noticed that the narrow 4-shank probes were easier to 
implant than the wide ones, probably because the shanks themselves were also narrower. 
Nonetheless, all probes could be inserted without force or visible damage to the nerve. 
Post-operative micro-CT scans confirmed that all probes were implanted in the cochlear 
nerve, although it was sometimes diﬃcult to confirm that the probe did not enter the 
inferior vestibular nerve (called the saccular nerve at this point), based on these images 
(Fig. 5a). All probes were implanted distal to the point where the singular canal meets the 
IAC, so it was impossible that they entered the posterior ampullar nerve. Even though we 
inserted the probes until resistance was felt, some of the probes did not fully traverse the 
cochlear nerve. In TB 6, on the other hand, the tip of the probe entered the FN after it 
crossed the cochlear nerve (Fig. 5B), which may be attributed to the fact that the angle 
with the MMA was the smallest, and the distance to the distal nerve end was the largest 
of the implanted TBs in the series. Also, this was one of the two TBs where the probe ran 
posterosuperior to the MMA and was directed too much cranially. Four out of 7 probes ran 
medially to the falciform crest at the level of the MMA.
Figure 6  A: Destruction of the cochlear aqueduct (*) in TB 4. White arrow indicates 
direction of the approach. RW: round window; CN: cochlear nerve. B: Destruction of the 
inferior cochlear vein (arrowhead) in TB 4. Part of the implanted probe is visible below the 
white arrow.
Figure 5  A: Micro-CT image of a 4-shank probe implanted in the cochlear nerve (CN) in 
TB 7. The inferior vestibular nerve (IVN) runs adjacent to the probe, but accidental insertion 
into this nerve cannot be ruled out with absolute certainty based on this image. Note the 
posterior ampullar nerve (PAN) next to the drill-hole. FN: facial nerve; SVN: superior 
vestibular nerve; V: vestibulum. B: Tip of the 4-shank probe inserted into the facial nerve 
(FN) after fully traversing the CN in TB6. The probe runs proximal to the falciform crest (FC).
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Both the distances PSC to JB and FN to JB in the TBs where the approach was unsuccessful 
(x = 1.92 and 9.56 mm, respectively), diﬀered significantly from the TBs in which the 
approach was successful (x = 10.99 and 13.25 mm, respectively), Ws = 3.00, z = -2.09, p = .04, 
r = -.66 for both (Wilcoxon rank-sum test). Parametric tests (disregarding the small sample 
size) suggests that the success of the approach might have a stronger correlation with the 
distance PSC to JB, rpb = .89, p (one-tailed) < .01, than with the distance FN to JB, rpb = .78, 
p (one-tailed) = .02 (Point-biserial correlations). The distances PSC to JB and FN to JB were 
also significantly correlated, rs = .82, p (one-tailed) < .01 (Spearman’s rho).
 The minimum distance between the PSC and the JB in the TBs where the approach 
was successful was 6.5 mm. The maximum distance in the TBs where the approach was 
unsuccessful was 2.4 mm. This means that the minimum distance that is required for this 
approach to be possible, probably lies somewhere between these 2 values, but our series 
was too small to provide a more accurate value.
 There was a significant negative relationship between the width of the shank(s) of the 
probe and percentage implantation depth (implantation depth / nerve diameter in the 
direction of implantation * 100%), τ = -.74, p (one-tailed) = .02 (Kendall’s tau). 
 There was no correlation between the length of the falciform crest and the probe 
crossing over into the FN.
7.4.  Discussion
There are only 2 reports on the infralabyrinthine approach from the perspective of 
cochlear nerve implantation that we are aware of. Middlebrooks et al. reported that a 
group of surgeons at the University of Michigan have explored the ILA to provide access 
to a peripheral portion of the nerve, but found that access was blocked by the JB in about 
one-third of the TBs 153. Paasche et al. used a surgical navigation system to find possible 
trajectories to the cochlear nerve without damaging the labyrinth in 5 human TBs. They 
attempted an approach in dorsomedial direction that is somewhat similar to the EILA and 
concluded that it provided the best access to the nerve, but that it was technically not 
feasible 133.
Most of the other literature on the infralabyrinthine approach to the IAC focuses on the 
possibilities to use this approach for vestibular nerve sectioning.   
 Including Vernick, a total of 13 patients that underwent vestibular nerve section using 
the ILA were reported in 3 studies. No intraoperative problems were encountered and 
hearing preservation was achieved in 10 patients. Technical diﬃculties were caused by 
anatomic variations such as a high JB or an anteriorly oriented SS, but the authors report 
that these obstacles can be easily overcome by carrying out the dissection at a higher 
level after cutting the endolymphatic duct or by depressing the sigmoid sinus and/or Ta
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extended into the neck, this would provide a posteroinferior access to the IAC that is 
optimal for cochlear nerve implantation. Whole cadaver surgery could be used to 
investigate this. 
Third, by drilling just medially from the round window niche towards the IAC, both the CA 
and the ICV are sacrificed. The CA extends from the basal turn of the cochlea towards the 
posterior cranial fossa and is thought to play a role in perilymphatic pressure regulation, 
but its exact role in inner ear physiology is not well understood. In a series of 101 
disease-free TBs, Gopen et al. found a patent aqueduct in 34 cases, an aqueduct filled with 
loose connective tissue in 60 cases and an aqueduct occluded by bone or fully obliterated 
in 7 cases 172. These findings, combined with reports on experimental occlusion of the CA 
in cats 173 and guinea pigs 139, where no influence on cochlear function and morphology 
was found, support the theory that obliteration of the aqueduct has no harmful eﬀects on 
inner ear function. 
 The ICV runs parallel to the CA and transfers the major portion of the venous blood 
from the cochlea, the utricle and the saccule to the dural sinus. The vein of the vestibular 
aqueduct, which drains in the SS, transfers venous blood from the three ampullae and 
semicircular canals. Collateral vessels exist between these two systems, but it is not well 
known if the vein of the vestibular aqueduct is able to process the complete venous 
drainage of the labyrinth when the ICV is occluded. Experiments in guinea pigs have 
shown that occlusion of the distal portion of the ICV leads to dilatation of some of the 
proximal vessels without significant changes on histological examination 142,174, while a 
more extensive occlusion of the vein can lead to reduction in blood flow, changes in cell 
structure and cochlear and vestibular function 140,175,176. However, the vein of the CA in 
guinea pigs is very small or might even be non-existent 143, so therefore these results are 
probably not directly applicable to man. Nonetheless, more knowledge on the venous 
drainage of the human labyrinth is necessary before this approach can be applied in 
patients with residual labyrinthine function. 
 Fourth, the EILA remains a complex procedure that risks damaging the FN, PSC, JB, 
posterior ampullar nerve and basal turn of the cochlea. Although the retrofacial air tract is 
known to be well-developed 177, its size is determined by the location of the JB and the SS. 
In our study, we did not encounter problems from an anteriorly positioned SS, but the 
distance between the PSC and the JB clearly determined if the approach was possible or 
not. We estimate the minimum distance PSC to JB that is necessary for the approach to 
succeed, to be about 3.0 mm, but a larger series is needed to determine this more 
precisely. The reported incidence of high JB varies highly according to the definition that 
is used, but based on our experience and the papers that list individual cases, we would 
estimate the incidence of a JB to PSC distance smaller than 3.0 mm to be about 10-35% 
163,164. Therefore, we would recommend to obtain a pre-operative CT scan and measure 
the distance PSC to JB, preferably in a multiplanar reconstruction, to assess whether the 
posterior fossa dura, respectively. Tomoda et al. also propose that a CT scan should be 
made prior to surgery 158-160. Because we had to pass in between the PSC and the JB, 
cutting the endolymphatic duct was not helpful in case of a high JB. We did not encounter 
problems from an anteriorly placed SS, probably because we passed in between the JB 
and the vertical segment of the SS after partial removal of the mastoid tip.  
Several temporal bone studies focused on the relevant surgical anatomy for both this 
approach and for access to the sinus tympani and the hypotympanum through the 
retrofacial air tract for the removal of pathologic lesions (such as glomus tumor or 
cholesteatoma). Because distance measurements were done either directly in the 
dissected temporal bones or in standard CT reconstruction planes, results cannot directly 
be compared to ours. Nevertheless, most authors confirmed our findings that JB position 
and anatomy are highly variable while the position of the FN and PSC, as well as the 
distance FN to PFD are relatively constant (except for Maniglia et al., who found a wide 
variation in all their distance measurements with a CV ~ 0.35) 161-164.
 The distances JB to PSC and JB to FN were considered critical in gaining access to the 
IAC. A high jugular bulb limited or blocked access to the IAC or sinus tympani in most 
cases and was reported in 6-20% of pediatric and 8-63% of adult temporal bones 164-167. 
There are a number of aspects of the surgical procedure itself that have to be taken into 
consideration before this approach can be applied clinically. First, there is very little known 
about the eﬀects and results of intraneural cochlear nerve stimulation in man. Histologic 
results of chronic implantation and stimulation in both animal and human subjects, 
ranged from little damage to nerve fibers 122,147 to extensive loss of spiral ganglion cells and 
axons, probably because of diﬃcult electrode insertion and chronic implant movement 
148. Currently, there is no commercially available intraneural auditory prosthesis and it is 
unknown how a modern intraneural implant will compare to a CI or an ABI in human 
subjects. If implemented, new speech processing strategies will need to be developed 
and postoperative mapping will probably be more challenging than with conventional 
CIs. 
 Second, in our study we used TBs that had all soft tissues removed and therefore we 
disregarded some of the steps that would be necessary in a real-life surgery. Because we 
lowered the posterior edge of the mastoid tip to the level of the SS, this would require 
sectioning the posterior part of the attachment of the sternocleidomastoid and digastric 
muscle on the mastoid tip. The procedure (which is considered standard in a canal wall 
down technique by some surgeons 168) has elsewhere been described as part of the 
infratemporal fossa approach without mobilization of the FN 169,170. We would therefore 
suggest to place the patient in a lateral position with the head rotated horizontally to 
minimize torsion to the contralateral jugular vein, as recommended by Miller et al. for all 
posterior petrosectomy procedures 171. In combination with a postauricular incision that is 
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EILA is blocked by a high JB or not. Various authors describe the technique for lowering a 
high JB for translabyrinthine surgery by skeletonizing the JB and pushing it downwards 
while applying bone wax and oxidised cellulose 178,179. Although this technique may even 
be applied with an intact labyrinth, it is argued that manipulation of the delicate bulb can 
lead to troublesome bleeding and compression may even cause neural injury 180. Taking 
all these points into consideration, the EILA should only be performed by an experienced 
otologic or skull base surgeon.
7.5.  Conclusion
With this study, we demonstrated the feasibility of using the EILA for the implantation of 
an intraneural auditory prosthesis in the human TB. The EILA has the advantage that it 
gives access to the most distal portion of the cochlear nerve with late opening of the dural 
space and sparing of the bony labyrinth. Contrary to the transcochlear approach, it gives 
a complete view on the cochlear nerve, allowing a more controlled implantation. The 
disadvantage is that it is a complex surgical procedure that can be complicated by a high 
JB. Pre-operative CT scanning is necessary to see whether access to the IAC is possible 
without lowering the JB. The distance between the PSC and the JB can serve as a good 
indicator for this. Implanting a probe using this approach brings the risk of the probe 
entering the FN after crossing the CN. This can be prevented by opening the IAC close to 
the fundus of the cochlea, implanting in the most distal portion of the nerve (at the level 
of the falcicorm crest) and aiming both laterally (thus creating a more than 90º angle with 
the MMA) and anteriorly. This means that the direction of implantation is diﬀerent from 
the trajectory of the approach. Furthermore, more research is necessary on the eﬀects of 
sacrificing the ICV, if this approach is to be applied in patients with residual labyrinthine 
function. Based on these results, we conclude that the EILA is a suitable approach for the 
implantation of an intraneural auditory prosthesis, when this is to be attempted in human 
subjects.
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Cochlear implantation has become standard care for restoring hearing in patients with 
congenital or acquired severe to profound bilateral hearing loss. Although results have far 
surpassed initial expectations, limitations such as reduced speech perception in noise and 
poor music appreciation remain. Most of these limitations are inherent to the implant 
design. Furthermore, complications rates remain relatively high compared to other 
fields of otologic surgery. This thesis explores several fields for improvement: low-dose 
computed tomography for postoperative imaging of the implant (to evaluate [new] 
electrode designs), medical complications and device failures in a large clinical series (to 
identify risk factors and reduce complications) and surgical approaches for cochlear nerve 
implantation (to investigate direct electrical nerve stimulation as an alternative for cochlear 
implantation). This chapter discusses the most important methodological considerations, 
provides a brief summary of the main findings and their implications on clinical practice, 
and directions for future research. 
8.1.  Methodological considerations
Two study designs were used in this thesis: human cadaver temporal bones studies and a 
retrospective chart review/observational study. Cadaveric studies allow safe investigation 
of (potentially) hazardous interventions (such as repeated radiation exposure and testing 
new surgical techniques), but their external validity always needs to be considered. The 
biggest issues concern the diﬀerence between a whole body or a sole temporal bone, 
and handling live or, in this case, formalin-fixed tissue. In the imaging study, this was 
largely overcome by using a human skull phantom. The implanted otic capsule was 
embedded in a plastic ring with formalin and gelatin to mimic radiation absorption similar 
to a human head. Nevertheless, this still remains a substitute for clinical conditions and 
real-life issues like motion artifacts are not taken into account. The same applies for the 
studies on cochlear nerve implantation: while surgical planning and execution may be 
feasible in temporal bones, that does not mean that the same procedure is straightfor-
ward in real patients. Blood, cerebrospinal fluid and surrounding soft tissue may limit 
visibility and make an actual implantation much more challenging. Nevertheless, cadaveric 
studies can be useful as an initial test of feasibility.
 Retrospective chart reviews are more prone to compromised internal validity, especially 
due to selection, and more important, confounding bias181,182. A diﬀerence between 
treatment groups may be caused by an inequality of the groups at baseline, and prognostic 
factors may influence treatment decisions (e.g. antibiotic prophylaxis may be given for a 
longer period of time in patients with middle ear inflammation during implantation). 
Although there are statistical methods to control for these types of bias, a randomized trial 
is the only way to truly avoid these problems. However, because serious complications are 
rare in cochlear implantation, a large sample size and long follow-up period are needed. 
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complication was coined, based on the one provided by the Dutch Federation of Medical 
Specialists100 and the recommendations of Jeppesen et al.39. Classifying these complications 
according to a validated system from general surgery (which is based on the type of 
therapy needed to treat the complication)95, further reduces any subjective interpretation 
of outcomes. Device failures should be distinguished from medical complications and be 
reported separately (based on international consensuses92,93). 
 A relational database system was created, based on forms with input masks and 
lookup functions, which allows fast and uniform data entry and reduces the risk of errors. 
This database, in combination with the definitions and classification system mentioned 
above, proved to be a very suitable method of registering adverse events. Nevertheless, 
correct registration of medical complications and device failures does not only depend on 
clear agreements and a suitable database system, but largely on the discipline of the 
caregivers involved in cochlear implantation.
 This database has been made freely available online, along with a manual that 
contains the definitions and classification system (http://bit.ly/cidatabasenijmegen). It is 
now in use in several international clinics. 
 Using this system, analysis of 1362 cochlear implantations that were performed in 
Nijmegen between 1987 and 2015, revealed a complication rate of 18.4% and a device 
failure rate of 2.9%. These rates are comparable to those reported in literature. Although 
most of the complications were minor (87% Clavien-Dindo grade I-II), there were 4 cases 
of wound infection leading to explantation and 3 cases of postoperative meningitis. In 
order to be able to prevent such complications in the future, a risk factor analysis was 
done. This revealed a higher rate of meningitis in patients with an inner ear malformation. 
Although there are several case reports on the association between inner ear malformation 
and meningitis103, this is the first study to demonstrate the association in cochlear implant 
patients (without a concurrent CSF leak97). No correlation between wound infections and 
the much-debated regimen of antibiotic prophylaxis105,194 was found, but there was a 
higher rate of wound infections in patients who were not vaccinated against Streptococcus 
pneumoniae. The clinical relevance of this finding is unclear since a study on bacterial flora 
on explanted CIs did not show the presence of Streptococcus pneumoniae106. Yet both are 
arguments for pneumococcal vaccine being administered to all patients scheduled for 
cochlear implantation.
 Despite intravenous antibiotics and surgical intervention, serious wound infections 
often lead to explantation of a cochlear implant, especially in cases with device exposure 
98,195. In 4 patients with a serious wound infection, gentamicin-impregnated collagen 
sponges have been used in salvage surgery to achieve higher implant survival rates, 
which was successful in 2 cases. Salvage surgery with gentamicin sponges might save the 
patient an extra procedure and may lead to significant cost savings, even if only half of the 
implants are preserved. 
A retrospective chart review can therefore provide valuable information to direct subsequent 
prospective studies.
8.2.  Postoperative imaging of cochlear implantation
Computed tomography (CT) is an important tool for evaluating the eﬀects of diﬀerent 
surgical approaches and electrode designs on the intracochlear position of the electrode 
array, and to correlate these results with speech perception scores155,183-187. Cone-beam CT 
(CBCT) has lately been described as a low-dose alternative to multi-slice CT (MSCT) for 
postoperative evaluation of cochlear implants that has superior image quality52,188-191. 
However, a dose-matched comparison of image quality had never been done. 
 This study confirms that CBCT requires only a fraction (6 to 16%) of the radiation dose 
used in clinical MSCT protocols. Some aspects of image quality (e.g. visibility of cochlear 
inner and outer walls and overall image quality) were positively correlated with radiation 
dose and therefore rated higher for clinical MSCT than for CBCT protocols. However, when 
applying dose reduction on MSCT to a dose level similar to CBCT, image quality is 
comparable to CBCT. Significant diﬀerences between systems were found (e.g. in spatial 
resolution), but not between CBCT and MSCT in general. 
 These findings contradict the general understanding that, by definition, CBCT is 
superior to MSCT for cochlear implant imaging, and especially the misconception that the 
cone-beam technique reduces metal artifacts192. Depending on the required information, 
clinical MSCT may even be preferred over CBCT and there is no need to use or purchase 
a CBCT scanner especially for these purposes. However, CBCT has other advantages such 
as allowing scanning in a sitting or supine position and moreover, these results may 
not apply to the newest generation CBCT scanners, which have a spatial resolution of up 
to 75 μm (compared to a resolution of around 250 μm in the newest MSCT scanners). 
 If postoperative CT imaging is necessary (for clinical issues or research questions) and 
MSCT is being used, it definitely needs to be considered if it is possible to apply a low-dose 
protocol (comparable to CBCT), especially since the increasing number of radiological 
examinations may lead to a higher risk of cancer, cardiovascular disease and cataract193.
8.3.  Complications and failures of cochlear implantation
While the number of medical complications reported in cochlear implantation is relatively 
high compared to other fields of otologic surgery, the variation in reported complication 
rates is even more notable (6-63%)37-39,81,82. This is largely due to the lack of consensus on 
how to define and grade adverse events. In order to achieve an objective registration of 
medical complications and make results more comparable, a strict definition of a medical 
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8.4.   Surgical planning and evaluation of cochlear  
nerve implantation
The limitations of current cochlear implants may be overcome by cochlear nerve implants. 
Animal studies have demonstrated that indeed, stimulation with a penetrating 
microelectrode interface leads to a lower spread of excitation, access to low-frequency 
fibers and lower energy requirements40. The next step is to find the most suitable surgical 
approach for cochlear nerve implantation in humans. Before the development of 
modern-day cochlear implants, several attempts have been made at cochlear nerve 
implantation, using a transmastoid-transcochlear approach (in 1957 and 196415,18, see 
chapter 1.5). This approach has the advantage of being extracranial and similar to that of 
cochlear implantation. Furthermore, it gives access to the distal end of the cochlear nerve, 
where it is separated from the facial and vestibular nerves and its movement is limited by 
its fixation to the cochlea. The optimal vector for such an approach that was determined 
in 10 3D models based on micro-CT scans of human temporal bones, runs through the 
anterior edge of the round window and through the inferior portion of the facial recess, 
intersecting the chorda tympani nerve in 7 out of 10 models. When this vector was used 
as a reference for the implantation of dummy probes in 3 of the temporal bones, the 
feasibility of this approach was confirmed, along with the necessity of sacrificing the 
chorda tympani nerve in 2 out of 3 cases (if cochlear integrity is to be preserved as much 
as possible). This approach is therefore suitable if cochlear nerve implantation is to be 
attempted in humans and the vector found is this study may serve as a guideline for 
drilling the transcochlear opening to the nerve. The dummy probes used for implantation, 
combined with the morphometric results of the 3D models and postoperative micro-CT 
scans, could form the basis for the development of a practical clinical device.
 Because the first real-life attempts at cochlear nerve implantation will probably be 
aimed at patients in whom cochlear implantation is diﬃcult (e.g. with obliterated or 
malformed cochleae) and because eventually, hearing preservation surgery will be 
preferred, an extracochlear surgical approach also needs to be considered. Transcranial 
approaches (such as the middle fossa, posterior fossa or retrosigmoid approach) carry the 
risks of a craniotomy, temporal lobe or cerebellar retraction and often only allow access to 
the medial part of the internal auditory canal, where nerve separation is poor at best196. 
Therefore, an extended infralabyrinthine approach was used to gain access to the cochlear 
nerve in 10 human formalin-fixed temporal bones. In 8 out of 10 temporal bones, it was 
possible to implant a dummy probe into the cochlear nerve. In the remaining 2, a high 
jugular bulb blocked access to the nerve. Success of the approach was related to the 
distance between the jugular bulb and the posterior semicircular canal, measured on 
pre-operative micro-CT scans. Although the extended infralabyrinthine approach is more 
challenging than the transcochlear approach (1 probe traversed into the facial nerve and 
in 2 cases, the basal turn was damaged), it is an alternative transmastoid approach that Fi
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gives a complete view on the cochlear nerve (allowing a more controlled implantation), 
and can preserve cochlear integrity. Although further research is necessary to determine 
the eﬀect of sacrificing the inferior cochlear vein on residual hearing, the chance of 
hearing preservation is probably higher than with the transcochlear approach. Therefore, 
the decision to choose for the transcochlear or the infralabyrinthine approach to the 
cochlear nerve could be based on residual hearing and the presence of a cochlear 
malformation (especially an absent modiolus). If the distance between the jugular bulb and 
posterior semicircular canal is smaller than 3 mm, an extended infralabyrinthine approach 
with depression of the jugular bulb, or a transcranial approach may be considered (Fig. 1). 
8.5.  Directions of future research
This thesis oﬀers several leads for further research. First, a comparison between image 
quality of the newest CBCT and MSCT scanners could be made in cochlear implant 
patients to investigate whether results are the same as in this temporal bone study. If that 
is indeed the case, regular MSCT scanners may be used (applying a low-dose protocol) in 
research on the eﬀects of new surgical approaches and electrode designs on electrode 
position, especially in centers where no CBCT scanner is available. 
 Second, this study has contributed to the identification, classification and quantification 
of complications as a basis for prioritizing new research. Further studies will be focused on 
the prevention and treatment of severe wound infections (which may lead to explantation) 
by investigating biofilm formation and the coating of implants, and prevention and 
treatment of chronic pain after implantation. Another subject of interest is the prevention 
of meningitis after cochlear implantation in patients with inner ear malformation.  The 
observation that malformed cochleae give a higher change for meningitis in CI patients 
will enforce the current thought that patients require recurrent vaccination. Research may 
be aimed at the identification of (subclinical) perilymphatic fistula in these patients, which 
can be repaired during implantation, preventing recurrent meningitis197.
 Third, the field of intraneural implantation oﬀers a broad range of topics for future 
research. With regard to the surgical approaches, an animal model with human-like 
anatomy may be used to study the eﬀects of the transcochlear and infralabyrinthine 
approach on vestibular and cochlear function. In addition, an actual cochlear nerve 
implant needs to be developed, which may be broadly similar to a contemporary cochlear 
implant with a multi-shank thin film microelectrode array, as used in this study. New 
speech processing and mapping strategies will need to be developed, which will probably 
be more challenging than with conventional cochlear implants. And before proceeding 
to human implantation, eﬀects of chronic implantation and stimulation may again be 
studied in an animal model.
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The implantable electronic device that in 1957 first provided a sense of sound in a deaf 
patient, was in fact a cochlear nerve implant. After a few practice sessions, the patient was 
able to recognize simple words in a closed set. This achievement served as an inspiration 
for the first cochlear implantation that was conducted in 1961 by William House. From 
there on, various clinics worldwide contributed to the development of the contemporary 
multichannel cochlear implant, that has become standard care for restoring hearing in 
patients with congenital or acquired severe to profound bilateral hearing loss. The history 
of cochlear implants is further described in chapter 1. 
 Although the outcome of cochlear implantation has risen far above the initial 
expectation that it would only be an aid for lipreading, there are still problems to overcome: 
individual performance variability is high, and speech perception in noise and music 
perception are limited in most cases. Furthermore, the rate of medical complications 
reported in cochlear implantation is considerable. This thesis explores three issues that 
can (directly or indirectly) help solve these problems. 
First, new electrode arrays are constantly being developed that intend to improve speech 
perception in noise and music appreciation by a more selective stimulation of neural 
populations, stimulating low-frequency nerve fibers and reducing insertional trauma. 
To evaluate the eﬀects of these new designs, it is vital to assess the intracochlear position of 
the electrode array in clinical trials, using (preferably low-dose) high resolution imaging 
techniques. Finding the most suitable low-dose imaging technique is discussed in chapter 2. 
 Five human cochleae were implanted with a cochlear implant and scanned on two 
cone-beam computed tomography (CBCT) and two multi-slice compute tomography 
(MSCT) systems. Four independent observers rated aspects of image quality on a 
five-point scale, comparing CBCT scans to clinical and dose-matched MSCT scans and 
declining-dose MSCT protocols to the clinical protocol. CT phantoms were used to 
determine eﬀective dose and resolution for each acquisition protocol. This confirmed that 
CBCT requires only a fraction (6 to 16%) of the radiation dose used in clinical MSCT 
protocols. Some aspects of image quality (e.g. visibility of cochlear inner and outer walls 
and overall image quality) were positively correlated with radiation dose and therefore 
rated higher for clinical MSCT than for CBCT protocols. However, when applying dose 
reduction on MSCT to a dose level similar to CBCT, image quality is comparable to CBCT. 
Significant diﬀerences between systems were found (e.g. in spatial resolution), but not 
between CBCT and MSCT in general.
Second, in order to reduce the number of medical complications in cochlear implantation, 
it is necessary to identify the most common and most severe complications. If risk factors 
can be found for these complications, adjustments in the surgical procedure or 
perioperative care may lead to a lower complication rate. This topic is elaborated in part III. 
In chapter 3, a method for the internationally uniform registration and classification of 
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In chapter 8, the outcomes of these studies are discussed. It was found that CBCT is ad- 
equate for postoperative imaging of cochlear implants. Nevertheless, dose reduction on 
MSCT can be achieved to a dose level similar to CBCT with an image quality comparable 
to CBCT. These findings contradict the general understanding that, by definition, CBCT is 
superior to MSCT for cochlear implant imaging, but these results may not apply to the 
newest generation CBCT scanners with higher resolution detectors. 
 The use of a custom database in combination with a strict definition of complications 
and failures, and a validated classification system proved to be a very suitable method of 
registering adverse events in cochlear implant surgery. Complication and failure rates are 
comparable to those reported in literature. The findings of a higher rate of meningitis in 
patients with an inner ear malformation and an increased rate of wound infections in 
patients who were not vaccinated against Streptococcus pneumoniae, both stress the 
importance of this vaccination. Salvage surgery with gentamicin sponges seems 
promising to achieve higher implant survival rates, but further research is necessary to 
prove this. 
 Both the transcochlear and extended infralabyrinthine approach are suitable for 
cochlear nerve implantation. Because the transcochlear approach probably has a higher 
chance of loss of residual hearing (although further research is necessary to determine the 
eﬀect of sacrificing the cochlear aqueduct and the inferior cochlear vein in the infralaby-
rinthine approach), the choice for either approach could be based on residual hearing, 
distance between the jugular bulb and the posterior semicircular canal and the presence 
of a cochlear malformation. 
 Future research could consist of clinical trials that compare the newest MSCT and 
CBCT scanners for postoperative imaging of cochlear implants, or preventing and treating 
severe wound infections and meningitis (especially in case of inner ear malformation) 
after cochlear implantation. Research in the field of intraneural implantation could focus 
on the eﬀects of chronic implantation and stimulation and comparison with cochlear 
implantation in an animal model, and the development of an actual implant.
complications is proposed. A custom database system was developed and made freely 
available online. Preliminary results showed that it enabled fast and accurate data entry 
and a medical complication rate of 19.0% in the patients registered thus far. The final 
results are described in chapter 4: when all 1362 implantations between 1987 and 2015 
were registered, the complication rate became 18.4% and a device failure rate of 2.9% was 
found. Analysis of possible risk factors revealed that there was a higher rate of hematoma 
in patients with a clotting disorder (5.1 vs. 0.9%, p = 0.009) and when a subtotal 
petrosectomy was performed (13.3 vs. 1.0%, p = 0.011), a higher rate of wound infections 
in patients who were not vaccinated against Streptococcus pneumoniae (5.7 vs. 2.6%, 
p = 0.031) and a higher rate of meningitis in patients with an inner ear malformation 
(2.3 vs. 0.1%, p = 0.012). In chapter 5, a novel way to manage serious postoperative 
infections using implantable gentamicin-impregnated collagen sponges, is reported. 
This was successful in 2 out of 4 cases.
Third, several limitations of contemporary cochlear implants (such as reduced speech 
perception in noise and poor music perception) may be overcome by cochlear nerve 
implants, because placing electrodes in direct contact with the target neurons reduces 
stimulation thresholds and spread of excitation. Also, low-frequency nerve fibers are more 
accessible with a penetrating microelectrode array. Because it is therefore worth 
reconsidering cochlear nerve implantation, the feasibility of penetrating cochlear nerve 
implantation in humans is explored in part IV. In chapter 6, ten 3D models based on 
micro-CT scans of human temporal bones were used to simulate a transmastoid-posterior 
tympanotomy approach to the cochlear nerve that would preserve the osseous spiral 
lamina, basilar membrane and floor of the scala tympani as much as possible. The optimal 
vector for such an approach runs through the anterior edge of the round window and 
through the inferior portion of the facial recess, intersecting the chorda tympani nerve in 
7 out of 10 models. When this vector was used as a reference for the surgical approach in 
3 of the temporal bones, its feasibility was confirmed, along with the necessity of 
sacrificing the chorda tympani nerve in 2 out of 3 cases. Postoperative micro-CT scans 
revealed that the probes were successfully implanted in the cochlear nerve, and the 
osseous spiral lamina and basilar membrane were intact in all 3 cochleae; however, the 
probe fully traversed the nerve in only one temporal bone.
 In chapter 7, micro-CT scans were obtained of 10 human temporal bones for 
morphometric evaluation. An extended infralabyrinthine approach was used to gain 
access to the cochlear nerve and implant a dummy probe, which was possible in 8 out of 
10 cases. In the remaining 2, a high jugular bulb blocked access to the nerve, which was 
related to the distance between the jugular bulb and the posterior semicircular canal in 
the preoperative scans. Post-operative micro-CT scans confirmed that all probes were 
implanted in the cochlear nerve, although 1 probe traversed into the facial nerve and in 2 
cases, the basal turn was damaged. 
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Het implanteerbare elektronische apparaat dat in 1957 voor het eerst tot geluidsperceptie 
leidde bij een dove patiënt, was in feite een cochleair zenuwimplantaat. Na een paar 
oefensessies was deze patiënt in staat om eenvoudige woorden uit een vaststaande reeks 
te herkennen. Deze prestatie diende als inspiratie voor de eerste cochleaire implantatie, 
die in 1961 werd uitgevoerd door William House. Sindsdien hebben diverse klinieken 
wereldwijd bijgedragen aan de ontwikkeling van het hedendaagse multikanaals cochleair 
implantaat, dat de standaardbehandeling is geworden voor het herstellen van gehoor bij 
patiënten met een aangeboren of verworven ernstig tot zeer ernstig bilateraal gehoor-
verlies. De geschiedenis van het cochleair implantaat wordt verder beschreven in hoofdstuk 1.
 Hoewel de resultaten van cochleaire implantatie ver uitstijgen boven de aanvankelijke 
verwachting dat ze slechts een hulpmiddel voor liplezen zouden worden, zijn er nog steeds 
problemen te overwinnen: er is een grote variatie in individuele uitkomsten, en het spraak- 
verstaan in rumoer en de muziekbeleving zijn in de meeste gevallen beperkt. Verder is het 
aantal medische complicaties bij cochleaire implantatie aanzienlijk. Dit proefschrift richt 
zich op drie vraagstukken die (direct of indirect) kunnen bijdragen aan het oplossen van 
deze problemen.
Ten eerste worden er voortdurend nieuwe elektrodes ontwikkeld met als doel om het 
spraakverstaan in rumoer en de muziekbeleving te verbeteren door een selectievere 
stimulatie van neurale populaties, het stimuleren van laagfrequente zenuwvezels en het 
verminderen van insertie trauma. Om de eﬀecten van deze nieuwe ontwerpen te evalueren, 
is het essentieel om de intracochleaire positie van de elektrodes te bepalen in klinische 
trials, door gebruik te maken van (bij voorkeur lage dosis) hoge resolutie beeldvormings-
technieken. Het vinden van de meest geschikte lage dosis beeldvormingstechniek wordt 
besproken in hoofdstuk 2.
 Vijf menselijke cochlea’s werden geïmplanteerd met een cochleair implantaat en 
gescand met twee cone-beam computed tomography (CBCT) en twee multi-slice computed 
tomography (MSCT) systemen. Vier onafhankelijke waarnemers beoordeelden aspecten 
van de beeldkwaliteit op een vijf-punts schaal, waarbij CBCT-scans werden vergeleken 
met klinische en dosis-gematchte MSCT-scans, en in dosis afnemende MSCT-protocollen 
met het klinische protocol. CT-fantomen werden gebruikt om de eﬀectieve dosis en 
resolutie per acquisitieprotocol te bepalen. Dit bevestigde dat CBCT slechts een fractie 
(6-16%) van de stralingsdosis gebruikt vergeleken met klinische MSCT-protocollen. Enkele 
aspecten van de beeldkwaliteit (bijvoorbeeld de zichtbaarheid van de cochleaire binnen- 
en buitenwanden en de algehele beeldkwaliteit) waren positief gecorreleerd met de 
stralingsdosis en werden daarom hoger gewaardeerd bij klinische MSCT dan bij CBCT- 
protocollen. Echter, wanneer de dosis van de MSCT-protocollen verlaagd werd tot het 
niveau van een CBCT-protocol, was de beeldkwaliteit vergelijkbaar met CBCT. Er werden 
significante verschillen tussen systemen gevonden (bijvoorbeeld in spatiele resolutie), 
maar niet tussen CBCT en MSCT in het algemeen.
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gehoorzenuw en de lamina spiralis en membrana basilaris intact waren in alle 3 de cochlea’s; 
echter doorkruiste de probe in slechts één geval de zenuw volledig.
 In hoofdstuk 7 werden micro-CT-scans van 10 menselijke ossa temporalia vervaardigd 
voor morfometrische evaluatie. Een uitgebreide infralabyrintaire benadering werd gebruikt 
om toegang tot de gehoorzenuw te verkrijgen en een dummy probe te implanteren, 
hetgeen in 8 van de 10 gevallen mogelijk was. In de resterende 2 blokkeerde een hoge 
bulbus jugularis de toegang tot de zenuw, en dat bleek gerelateerd te zijn aan de afstand 
tussen de bulbus jugularis en het posterieure semicirculaire kanaal in de preoperatieve 
scans. Met postoperatieve micro-CT-scans werd bevestigd dat alle probes in de nervus 
cochlearis geïmplanteerd waren, hoewel 1 probe in de nervus facialis door liep en in 2 
gevallen de basale winding beschadigd werd.
 In hoofdstuk 8 worden de uitkomsten van deze onderzoeken besproken. Het bleek 
dat CBCT adequaat is voor postoperatieve beeldvorming van cochleaire implantaten. 
Niettemin kan verlaging van de dosis van MSCT worden bereikt tot het niveau van CBCT, 
met een beeldkwaliteit die vergelijkbaar is met CBCT. Deze bevindingen spreken de 
algemene veronderstelling tegen dat CBCT per definitie superieur is aan MSCT voor 
beeldvorming van cochleaire implantaten, maar deze resultaten zijn mogelijk niet van 
toepassing op de nieuwste generatie CBCT-scanners met hogere resolutie detectoren.
 Het gebruik van een custom-made database in combinatie met een strikte definitie 
voor complicaties en implantaatuitval, en een gevalideerd classificatiesysteem bleek een 
zeer geschikte methode voor het registreren van nadelige uitkomsten bij cochleair 
 implantaatchirurgie. De percentages van complicaties en implantaatuitval zijn vergelijkbaar 
met die in de literatuur. De bevindingen van een hoger percentage van meningitis bij 
patiënten met een binnenoor malformatie en een verhoogd aantal wondinfecties bij 
patiënten die niet tegen Streptococcus pneumoniae gevaccineerd waren, benadrukken 
beiden het belang van deze vaccinatie. Chirurgische behandeling met gentamicine 
sponzen lijkt veelbelovend om een hogere implantaatoverleving te bereiken bij ernstige 
wondinfecties, maar verder onderzoek is nodig om dit te bewijzen.
Zowel de transcochleaire als de uitgebreide infralabyrintaire benadering zijn geschikt voor 
cochleaire zenuwimplantatie. Omdat de transcochleaire benadering waarschijnlijk een 
hogere kans geeft op verlies van het restgehoor (hoewel verder onderzoek nodig is om 
het eﬀect van het opoﬀeren van de aqueductus cochlearis en de vena cochlearis inferior 
in de infralabyrintaire benadering te bepalen), kan de keuze voor een bepaalde benadering 
gebaseerd worden op de aanwezigheid van restgehoor of een cochleaire malformatie, en 
de afstand tussen de bulbus jugularis en het posterieure semicirculaire kanaal.
 Toekomstig onderzoek zou kunnen bestaan uit het vergelijken van de nieuwste 
MSCT- en CBCT-scanners voor postoperatieve beeldvorming van cochleaire implantaten, 
of de preventie en behandeling van ernstige wondinfecties en meningitis (vooral bij 
binnenoor malformatie) na cochleaire implantatie. Onderzoek op het gebied van intra- 
Ten tweede, om het aantal medische complicaties bij cochleaire implantatie te verminderen, 
is het noodzakelijk om de meest voorkomende en meest ernstige complicaties te 
identificeren. Als risicofactoren voor deze complicaties kunnen worden gevonden, zou 
aanpassing van de chirurgische procedure of de peri-operatieve zorg kunnen leiden tot 
een lager percentage complicaties. Dit onderwerp is uitgewerkt in deel III.
 In hoofdstuk 3 wordt een methode voor internationaal uniforme registratie en classificatie 
van complicaties voorgesteld. Er werd een databasesysteem ontwikkeld en online vrij 
beschikbaar gesteld. Voorlopige resultaten toonden aan dat hiermee snelle en accurate 
data invoer mogelijk was en er werd een medisch complicatiepercentage van 19,0% in de 
tot dan toe ingevoerde patiënten gevonden. De eindresultaten worden beschreven 
hoofdstuk 4: nadat alle 1362 implantaties tussen 1987 en 2015 waren geregistreerd, werd 
een complicatiepercentage van 18,4% en een implantaatuitval van 2,9% gevonden. 
Bij analyse van mogelijke risicofactoren bleek er sprake te zijn van een hoger percentage 
hematomen bij patiënten met een stollingsstoornis (5,1 versus 0,9%, p = 0,009) en wanneer 
er een subtotale petrosectomie was uitgevoerd (13,3 versus 1,0%, p = 0,011), een hoger 
percentage wondinfecties bij patiënten die niet tegen Streptococcus pneumoniae waren 
gevaccineerd (5,7 versus 2,6%, p = 0,031) en een hoger percentage meningitiden bij 
patiënten met een binnenoor malformatie (2,3 versus 0,1%, p = 0,012). In hoofdstuk 5 
wordt een nieuwe manier om ernstige postoperatieve infecties te behandelen met 
implanteerbare, met gentamicine geïmpregneerde collageen sponzen besproken. Dit was 
succesvol in 2 van de 4 gevallen.
Ten derde, zouden een aantal beperkingen (zoals verminderd spraakverstaan in rumoer 
en slechte muziekbeleving) van moderne cochleaire implantaten kunnen worden 
ondervangen door middel van cochleaire zenuwimplantaten, omdat het in direct contact 
plaatsen van elektrodes met de doelneuronen stimulatiedrempels en verspreiding van 
excitatie vermindert. Ook zijn laagfrequente zenuwvezels beter te stimuleren met een 
penetrerende micro-elektrodereeks. Omdat het hierdoor de moeite waard is om 
cochleaire zenuwimplantatie te heroverwegen, wordt de haalbaarheid van penetrerende 
cochleaire zenuwimplantatie bij mensen onderzocht in deel IV. In hoofdstuk 6, werden 
tien 3D-modellen van micro-CT-scans van menselijk ossa temporalia gebruikt om een 
transmastoidale-posterieure tympanotomie benadering van de cochleaire zenuw te 
simuleren, waarbij de benige lamina spiralis, de membrana basilaris en de bodem van de 
scala tympani zoveel mogelijk intact zouden blijven. De optimale vector voor een 
dergelijke benadering loopt door de voorste rand van het ronde venster, door het 
onderste gedeelte van de recessus facialis en kruist de chorda tympani in 7 van de 
10 modellen. Wanneer deze vector werd gebruikt als referentie voor de chirurgische 
benadering in 3 van de ossa temporalia, werd de haalbaarheid bevestigd, samen met 
de noodzaak van het opoﬀeren van de chorda tympani in 2 van de 3 gevallen. Uit post- 
operatieve micro-CT-scans bleek dat de probes met succes geïmplanteerd waren in de 
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neurale implantatie zou zich kunnen richten op de eﬀecten van chronische implantatie 
en stimulatie, een vergelijking met cochleaire implantatie in een diermodel, en de 
ontwikkeling van een klinisch bruikbaar implantaat.
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CA:  cochlear aqueduct
CBCT:  cone-beam computed tomography 
CI:  cochlear implant
CN:  cochlear nerve
CSF:  cerebrospinal fluid
CTDI:  computed tomographic dose index
CTN:  chorda tympani nerve
CV:  coeﬃcient of variation
DNE:  distal nerve end
EILA:  extended infralabyrinthine approach 
FC:  falciform crest
FN:  facial nerve
FWHM:  full-width at half maximum
GPN:  greater petrosal nerve
HU:  Hounsfield units
IAC:  internal auditory canal
ICU:  intensive care unit 
ICV:  inferior cochlear vein
IVN:  inferior vestibular nerve
JB:  jugular bulb 
ME:  middle ear
MMA:  mid-modiolar axis
MPR:  multi-planar reconstruction
MSCT:  multi-slice computed tomography
MT:  mastoid tip
OSL:  osseous spiral lamina
PAN:  posterior ampullar nerve
PFD:  posterior fossa dura 
PSC:  posterior semicircular canal 
PSF:  point-spread function
RW:  round window
TB:  temporal bone 
SF:  singular foramen
SS:  sigmoid sinus
ST:  scala tympani
SV:  scala vestibuli
SVN:  superior vestibular nerve
VI |  Appendices
13.  Acknowledgments
Acknowledgments | 143
Mijn dank gaat uit naar de volgende personen:
Prof. dr. E.A.M. Mylanus. Beste Emmanuel, mijn promotie is misschien wat anders gelopen 
dan oorspronkelijk gepland, maar ik wil je bedanken voor je inspirerende ideeën die alles 
in gang hebben gezet en de vrijheid die je mij daarbij hebt gegeven. In je omgang met 
patiënten en als oorchirurg ben je een voorbeeld voor mij. En gezamenlijk skiroute 40 
afdalen blijft legendarisch.
Prof. dr. H.A.M. Marres. Beste Henri, hoewel je pas op het einde bij mijn promotie betrokken 
raakte, wil ik je bedanken voor je kritische blik en organisatorische bijdrage. Ik heb 
bewondering voor je werk als KNO-arts en afdelingshoofd, en als mijn opleider wist je er 
op het juiste moment te zijn. 
Prof. M. Gotthardt. Beste Martin, je was meteen enthousiast om mee te doen met onze 
micro-CT studie. Bedankt voor je hulp bij het vervaardigen van de scans en geduld bij de 
reconstructies.
Dr. B.M. Verbist. Beste Berit, je hebt een enorme bijdrage geleverd aan onze CT studie. 
Ik heb veel van je geleerd op radiologisch vlak en wil je bedanken voor de prettige 
samenwerking.
Dr. J. Geleijns en dr. R.M.S. Joemai. Beste Koos en Raoul, dank voor jullie hulp bij de 
dosimetrie, resolutiemetingen en beoordelingen van alle CT-scans, en jullie waardevolle 
bijdrage aan ons artikel.
Dr. T.J.J. Maal. Beste Thomas, bedankt voor je expertise op het gebied van de cone-beam 
CT en het vervaardigen van alle scans.
Mw. E. Buijs, MSc. Beste Elvi, bedankt voor je goede werk aan ons artikel over de genta- 
matjes. 
Drs. E. Dekkers. Beste Esther, bedankt voor je hulp bij het doorspitten van de CI-statussen 
en het bijhouden van de complicatiedatabase.
Dhr. A.P.W. Meeuwis. Beste Antoi, bedankt voor je hulp bij de (vaak frustrerende) 
reconstructies van de micro-CT scans.
144 | Appendices Acknowledgments | 145
Staf KNO van het Radboud umc en ‘maatschappen’ KNO van het VieCurie en (mijn huidige 
en oud-collega’s) van het CWZ. Bedankt voor jullie bijdrage aan mijn opleiding tot 
KNO-arts. In het bijzonder de Otologen van het Radboud umc: jullie hebben mij zowel 
tijdens mijn opleiding als daarna veel hulp en ruimte geboden voor het ontwikkelen van 
mijn chirurgische vaardigheden. 
Mijn oud-collega AIOS KNO van het Radboud umc. Het is bijzonder als je collega’s vrienden 
worden, zorg dat die sfeer behouden blijft.
Al mijn vrienden. In het bijzonder Arthur, Bimmer, Jasper, Jillis, Michiel, Noud en Rinke. 
We hebben samen veel geweldige herinneringen gemaakt en daar gaan er ongetwijfeld 
nog veel bijkomen.
Mijn broertje Frank, en Jelke. We hebben altijd een prachtige tijd samen.
Mijn ouders. Lieve papa en mama, bedankt voor jullie onvoorwaardelijke liefde en steun.
Lieve Leonie, Guus en Willem. Jullie maken mijn leven fantastisch.
VI |  Appendices
14.  Curriculum Vitae
Curriculum Vitae | 149
Erik Theunisse werd op 7 december 1982 geboren in Nijmegen. 
Hij groeide op in Beuningen en behaalde zijn gymnasiumdiploma 
aan het Canisius College in Nijmegen. Hij studeerde Geneeskunde 
aan de Radboud Universiteit. Tijdens zijn studie volgde hij het inter-
disciplinaire Honours Programma en was onder andere actief als 
praeses van de medische faculteits vereniging (MFVN). Na zijn studie 
startte hij als arts-onderzoeker aan de afdeling KNO-heelkunde van 
het Radboud umc, waar hij in 2010 begon aan zijn opleiding tot 
KNO-arts. Gedurende zijn opleiding was hij enkele jaren voorzitter van de arts-assistenten-
vereniging (AAVR) en nam hij zitting in de Centrale Opleidings Commissie. Hij diﬀeren-
tieerde zich in de Otologie en is sinds 2016 werkzaam in het Canisius-Wilhemina ziekenhuis 
als KNO-arts met als aandachtsgebied de sanerende en reconstructieve oorchirurgie. 
Hij woont sinds 2010 samen met Leonie en is de trotse vader van Willem en Guus.
VI |  Appendices
15.  List of publications
List of publications | 153
Theunisse HJ, van den Hoogen FJ. Airway obstruction due to inflammatory myofibroblastic 
tumour of the posterior pharyngeal wall. J Laryngol Otol. 2011 Jun;125(6):655-9.
Theunisse HJ, Gotthardt M, Mylanus EA. Surgical planning and evaluation of implanting a 
penetrating cochlear nerve implant in human temporal bones using microcomputed 
tomography. Otol Neurotol. 2012 Aug;33(6):1027-33
Theunisse HJ, Mulder JJ, Pennings RJ, Kunst HP, Mylanus EA. A database system for the 
registration of complications and failures in cochlear implant surgery applied to over 1000 
implantations performed in Nijmegen, The Netherlands. J Laryngol Otol. 2014 Nov;128(11): 
952-7.
Theunisse HJ, Joemai RM, Maal TJ, Geleijns J, Mylanus EA, Verbist BM. Cone-beam CT versus 
multi-slice CT systems for postoperative imaging of cochlear implantation--a phantom 
study on image quality and radiation exposure using human temporal bones. Otol 
Neurotol. 2015 Apr;36(4):592-9. 
Buijs EF, Theunisse HJ, Mulder JJ, van den Hoogen FJ, Oﬀeciers EF, Zarowski AJ, Mylanus EA. 
The use of gentamicin-impregnated collagen sponges (Garacol®/Duracoll®) in cochlear 
implant infections: our experience in four cases. Clin Otolaryngol. 2015 Oct;40(5):492-5.
Rohof D, Honings J, Theunisse HJ, Schutte HW, van den Hoogen FJ, van den Broek GB, 
Takes RP, Wijnen MH, Marres HA. Recurrences after thyroglossal duct cyst surgery: Results in 
207 consecutive cases and review of the literature. Head Neck. 2015 Dec;37(12):1699-704.
Theunisse HJ, Pennings RJ, Kunst HP, Mulder JJ, Mylanus EA. Risk factors for complications 
in cochlear implant surgery. Eur Arch Otorhinolaryngol. 2018 Epub ahead of print.

